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ABSTRACT OF DISSERTATION 
 
USE OF GENOMIC TOOLS TO DISCOVER THE CAUSE OF  
CHAMPAGNE DILUTION COAT COLOR IN HORSES AND TO MAP THE 
GENETIC CAUSE OF EXTREME LORDOSIS  
IN AMERICAN SADDLEBRED HORSES   
 
Champagne dilution of coat color in horses is caused by dominant gene action.  
Three sire families were identified as segregating for this trait. Genome wide linkage 
analysis using 104 microsatellite DNA markers was used to map the gene to ECA14 
(LOD > 11.0). Four genes, namely SPARC, SLC36A1, SLC36A2 and SLC36A3, were 
selected from the region implicated by linkage and their exons sequenced to identify 
genetic variation. DNA sequences were compared for two homozygotes for Champagne 
dilution, two heterozygotes and two horses without dilution. A single base change in 
exon 2 of SLC36A1 was found unique to horses exhibiting Champagne dilution.  
SLC36A1 encodes a eukaryote specific proton dependent small amino acid transporter 
also known as LYAAT-1 in rats. This change in base 188 of the cDNA from a C to a G 
(Genbank REFSEQ: Non-champagne EU432176 and Champagne EU432177), is 
predicted to cause an amino acid change from threonine to arginine in the first 
transmembrane region of the protein. This may disrupt placement of the transmembrane 
portion of the protein in the membrane interrupting function of the ion channel. No 
exceptions to the association of this mutation with the Champagne dilution (CH) allele 
were identified based on testing 182 additional horses representing 15 breeds, suggesting 
that this mutation may be the causative for the dilution phenotype. While this gene is 
expected to function as a proton/amino acid symporter based on its sequence and gene 
family, this observation for the horse is the first evidence for a phenotypic effect of 
mutation of the gene. Identifying this variant also gives breeders a new tool for selecting 
breeding stock with or without this dilution genotype. 
 
Extreme lordosis is a condition in which the dorsal to ventral curvature of the 
back is accentuated. The condition is considered a conformation fault by many 
Saddlebred breeders and is commonly referred to as swayback, softback or lowback.   
Previous studies suggested the existence of a hereditary component in American 
Saddlebred horses.  A whole genome association study was performed utilizing the 
Illumina SNP50 beadchip containing over 59,000 SNPs.  A 3 Mb region on ECA20 was 
found associated with extreme lordosis.  The distribution of markers indicated that the 
trait had a simple Mendelian recessive mode of inheritance.  Subsequently, the 
association was confirmed and the region was narrowed to just over 500 kb by a higher 
density SNP assay using 47 SNPs selected from the equine SNP database.  Identification 
of this associated region will allow future studies a better opportunity to locate the 
mutation responsible for the lordotic phenotype in young American Saddlebred Horses. 
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CHAPTER ONE:  Gene Mapping and Current Applications in Horses 
 
Introduction 
 Genetic tools have been valuable for medical and agricultural research. 
Applications of genetics have led to understanding of basic phenotypic variations, 
diseases, pathogens and the creation of therapeutic treatments. With the advent of 
improved molecular genetic techniques and the completion of whole genome sequences 
for many livestock species, including the horse, scientists have uncovered genes related 
to diseases, color patterns and performance traits. This dissertation describes two 
approaches to gene discovery used to investigate a coat color gene (Champagne dilution) 
and a morphological trait (extreme lordosis). The work is a product of modern technology 
but has deep roots in the history of genetics.   
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Section I: Nature of Natural and Artificial Selection 
 
Natural Selection  
In the middle of the 19th century, Charles Darwin, an English naturalist, noted that 
organisms within a species possess individual differences which are less pronounced in 
populations living in confined regions, but exhibit more pronounced variations between 
populations of different regions, especially with differing environmental pressures 
(Darwin, 1859). Inherited variation and evolution had long been recognized before 
Charles Darwin published his book On the Origin of Species, but he recognized natural 
selection as the subtle, but powerful, force that joined these two observations.  Darwin 
did not know how genetic variation originated but he recognized that when it occurred, 
resulting differences enabled some individuals in a population to be more efficient in 
obtaining food and reproducing.  Those individuals would leave more offspring leading 
to an increase in that genetic variant in future generations. He proposed that changes in 
the environment and changes in genetic variation could lead to evolution of new species.  
Variables in nature were the driving force of selection. One of his examples is the 
difference among beak functions and sizes possessed by finches populating different 
isolated islands of the Galapagos archipelago. He deduced differences such as these were 
under selective pressure from the environment and must have conferred reproductive 
advantage in order to get passed on from one generation to the next generation (natural 
selection).   
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Artificial Selection  
One of the major arguments that Darwin advanced about the power of natural 
selection was derived from observations of artificial selection (Darwin, 1859). Artificial 
selection exemplified by plant cultivation and animal domestication in which people 
select for plants and animals that have desirable traits.  Over time, artificial selection has 
led to production of wheat with higher yields, faster growth in livestock and greater 
power and speed among horses. Farmers select the most phenotypically desirable 
individuals for reproduction of the next generation, leading to varieties distinct from 
those found in nature, but are superbly adapted to agricultural use. This continued desire 
to reproduce desirable traits and avoid undesirable ones for efficiency and profitability is 
a driving force behind continued advances in molecular technologies and research.  
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Selective Pressure 
Selective pressure can be the result of natural selection in the wild, such as the 
female mocking bird’s selection of a mate depending upon his song or ecological 
selection caused by a trait making an individual more fit for reproduction in a particular 
environment. This pressure can also be the result of artificial selection as described 
above. Disease causing genes can be under selective pressure within certain populations.  
Genetic variants can be subjected to negative and positive selection at the same time.  If 
the selection pressures are equivalent, then the genes are said to be under balanced 
selection and the variant will be maintained in the population.   
The genetics of thalassemia, a microcytic anemia, is a good example of how 
selective pressure can result in fixation of an otherwise abnormal gene in a population. 
The genetic variant α-thalassemia has been found in a uniformly high frequency in Tharu 
people of Southern Nepal. Most Tharu people are homozygous for the α-/α-genotype, 
with an overall α-thal gene (α-) frequency of .8 in the population. It is suggested that 
holoendemic malaria resulted in preferential survival of people with α-thal genetic 
variant, enabling this population to survive for centuries despite the high occurrence of 
malaria (Modiano et al., 1991). Higher frequencies of the genes for sickle cell anemia, 
Glucose-6-phosphate dehydrogenase deficiency and Hemoglobin C are also associated 
with selective pressure from malaria in areas of Africa and around the Mediterranean 
region (Allison 1954; Ruwende and Hill, 1998 and Agarwal et al., 2000).  
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Section II: Discrete Nature of Genes 
 
Gregor Mendel, an Augustinian friar and Austrian scientist, established that the 
inheritance of particular traits in peas followed set patterns.  He studied traits that were 
easy to characterize and only occurred in one of two forms; such as; yellow or green 
seeds, tall or short stems, white or purple flowers.  He proposed that traits are passed on 
from parent to progeny as descrete units (later called genes). He characterized these genes 
as being dominant or recessive; dominant genes were always expressed in at least one 
parent while recessive genes would not be expressed unless two copies were present; one 
inherited from each parent.  His work led to two major conclusions. First, one of the two 
genes in a parent is passed to its offspring (Law of Segregation). Second, genes for 
separate traits are passed on to offspring independent of one another (Law of Independent 
Assortment) (Mendel, 1866).  These basic principles of genes and heredity were 
reestablished independently by three scientists around 1900 (deVries, 1890; Correns, 
1900; von Tschermak-Seysenegg, 1900-1901) who are collectively credited with 
rediscovery of Mendel’s Laws of Independent Assortment and Segregation.  
As an interesting side note, during this same period, the presence of chromosomes 
in the cell nucleus was noted by cytologists including Walther Flemming, Wilhelm von 
Waldeyer-Hartz and Edouard Van Beneden (Flemming, 1878; Waldeyer-Hartz, 1888).  
After the turn of the century, the relationship between chromosomes and heredity was 
first suggested by Theodor Boveri and expanded upon by Walter Sutton (Sutton, 1902). 
Morgan (1910) proved that chromosomes are the source of hereditary material.   
Mendel’s basic laws of heredity are the foundation of current studies to identify 
the genes responsible for simple and complex traits. During the 1900s many Mendelian 
genes were uncovered, one of the most famous being the ABO blood group system.  In 
1900, Karl Landsteiner identified four blood types A, B, AB and O in humans; however 
the specific genetic basis underlying the ABO system was not described until 24 years 
later (Bernstein 1924) 
 
 
 
5 
 
 
Modes of Inheritance 
The mode of inheritance is the manner in which a gene and its corresponding 
phenotype are passed down from one generation to another.  Modal inheritance patterns 
can be categorized as follows; autosomal dominant, autosomal recessive, X-linked 
dominant, sex-linked, complex and mitochondrial.  (Autosomes are the chromosomes 
that occur in duplicate pairs in individuals, one coming from each parent; Sex 
chromosomes are the X and the Y chromosome that determine the gender of the 
individual.)  Autosomal dominant genes are always phenotypically expressed when 
present, whether occurring as a singleton or in duplicate.  If the gene has a different effect 
when present in two copies, then it is referred to as an incomplete dominant gene. Cream 
dilution in horses has an incomplete dominant mode of inheritance as shown by the 
dilution of brown pigment when present in one copy and dilution of all pigment when 
present in two copies (Adalsteinsson, 1974).  Autosomal recessive conditions are only 
manifested in individuals bearing two copies of the variant allele, or, to put it another 
way, in the absence of a dominant gene.  Chestnut coat color is due to a recessive gene 
resulting in a loss of function variation that prevents production of black pigment 
(Marklund et al., 1996).  
Sex linked inheritance is associated with genes on the X or Y chromosome in 
mammals.  Females have two copies of the X chromosome while males have only one X 
and one Y chromosome.  Males possess a single copy of genes on the X chromosome and 
will express whatever gene is present.  As a consequence, genes which are recessive and 
rarely detected in females are readily expressed in males.  Males are said to be hemi-
zygous for the X chromosome since they have but one copy.  X-linked recessive traits are 
manifested in females where both X chromosomes bear the variation and in males 
carrying just the single X chromosome with the causative variation. Hemophilia is a 
hemorrhagic disease inherited as a sex linked recessive trait.  Queen Victoria of England 
was a carrier of hemophilia.  It was long speculated which form of hemophilia was 
carried by the royal family and no living carriers exist.  Discovery of tombs containing 
Czar Nicolas II’s entire family provided the necessary genetic material, namely from 
Czar Alexis who had the disease. This led to the discovery that the royal hemophilia was 
hemophilia B caused by a mutation of the F9 gene (Lannoy and Hermans, 2010) 
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Some phenotypically similar traits have heterogeneous origins, with different 
genetic variations within the same gene responsible for a common phenotype, such as is 
the case with Dominant White in horses.  In some horse breeds all white or partial white 
horses arise from the matings of solid colored parents.  In many of these cases the white 
color is inherited as a monogenic autosomal dominant trait that spontaneously arose in 
one of the parent’s germ line cells (Haase et al., 2007, Haase et al., 2009, Haase et al., 
2010).  Duchenne’s muscular dystrophy (Emery, 1984) is the result of many different 
individual variations, some of which occurred spontaneously in germ line cells.  Genetic 
variations in different genes can also cause a single phenotype.  Osteogeneisis imperfecta 
(OI) is a connective tissue disorder with different genes (namely collagen gens and genes 
coding for proteins that form complexes with them) responsible for different types of OI.   
Complex inheritance is the result of multiple genes, their interactions with other 
genes and/or interactions with the environment, all playing a role in the risk of disease or 
trait development.  Athletic performance is influenced by training in addition to 
hereditary characters influencing strength, endurance, speed and intellect.  For example: a 
287 bp in/del identified in the angiotensin converting enzyme, ACE gene, was found to 
be associated with serum levels of the product enzyme (Rigat et al., 1990).  Frequency of 
the insertion allele was also found to be associated with endurance 1996 study of 
Australian rowers (Gayagay et al., 1998).  In a study of British mountaineers, the ACE 
insertion allele was associated with the ability to climb greater than 8000 feet without 
oxygen with no deletion homozygotes present in this elite group.  The deletion genotype 
has been found to be associated with sprinters and short distance swimmers (Montgomery 
et al., 1998).  Observed associations such as this only account for part of the heritability 
of these traits.  There are other yet unknown genes involved in these abilities or 
phenotypes.   
Mitochondria are organelles found in the cytoplasm of cells; mitochondrial DNA 
is a closed circular molecule 16,569 bp long, encodes 13 genes and is only inherited from 
the mother (Anderson et al., 1981, Giles et al., 1980).  Many of the inherited 
mitochondrial disorders are due to mutations in the approximately 1500 nuclear genes 
that are targeted to the mitochondria and only half of which have been identified (Calvo 
et al., 2006).  
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Linear Organization of Genes and Recombination  
The first linkage between genes was discovered, but not understood, in studies of 
dihybrid crosses in pea plants similar to Mendel’s work, by William Bateson, Edith 
Rebecca Saunders and Reginald Punnett (Bateson et al., 1905). This linkage between 
traits was later elucidated by Thomas Hunt Morgan in his studies of Drosophala 
melanogaster (fruit flies) at Columbia University.  Morgan ascertained the presence of 
the discrete hereditary sex determining unit known as the X chromosome in breeding 
experiments with a white eyed fly (Morgan, 1910).  He observed co-segregation of white 
eyes and gender corresponded with the presence of chromosomes. Morgan suspected 
crossing over/recombination of chromosomes when he noticed that the “linked” traits of 
small wing and white eye would sometimes separate (Morgan, 1911).  Morgan’s student, 
Alfred Sturtevant, was able to calculate the linear genetic relationship between the trait 
loci and piece together the first map of genetic linkage by calculating recombination 
frequency/crossing over events between linked loci (Sturtevant, 1913).  This research 
demonstrated that genes were discrete hereditary units which were joined in a linear 
arrangement in relation to one other like beads on a string (Sturtevant and Beadle, 1939).  
Some chromosomes are very large and it is not possible to detect linkage between genes 
residing on opposite ends of a chromosome.  Therefore, the presence of testable markers 
that give good coverage of a chromosome is important. 
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Section III: Nature of Genetic Variation 
Every cell of mammals, except germ line cells, contains the full complement of 
DNA, called the genome.  Its code is comprised of different combinations of only four 
bases; adenine, thymine, guanine, and cytosine (A, T, G, C).  Phenotypic differences in 
organisms are the result of physical and structural changes to this code.  There are also 
many physical and structural differences of the DNA that will not be associated with 
phenotypic differences.  These variations present in the genome are discussed below. 
 
 SNPs 
Single nucleotide polymorphisms, SNPs, are a single base change in the sequence 
of DNA.  In 2001 a human SNP map was compiled using 1.42 million SNPs.  This 
included all the SNPs that were publically available from multiple sources in November 
of 2000.  This indicated about one SNP per 1.9 kbp.  An estimated 60,000 of these SNPs 
were believed to fall within coding regions (Sachidanandam et al., 2001).  By 2008, a 
sequencing project of an individual person identified over 3 million SNPs.  This indicates 
the presence of approximately 1 SNP per 1000 bases.  More than 10,000 of the SNPs 
cause amino-acid substitutions in known coding sequences (Wheeler et al., 2008).  The 
number of SNPs present in the genome can vary among other species, as the grapevine 
(Vitis vinifera L.) has SNPs occurring one in every 47 bp in non-coding regions and one 
in 69 bp in coding regions (Lijavetzky et al., 2007)  
 
Insertions and Deletions: In/Dels 
Insertions and deletions (IN/DELS) can involve a single base or several thousand 
bases and have the potential to cause disease or phenotypic change if they occur in a 
location that alters a gene’s transcript or expression. Messenger RNA transcripts are read 
by the translation machinery in sets of three base pairs at a time, called codons. The 
insertion or deletion of a single base, or any group of bases not in a multiple of three, 
results in a “frameshift”. A frameshift results in a different codon reading frame from the 
point forward from a mutation resulting in an altered product or introducing a premature 
stop codon. 
9 
 
 
Duchenne’s (DMD) and Becker’s (BMD) Muscular Dystrophy are examples of 
genetically heterogenous X-linked recessive lethal diseases caused by various deletions, 
duplications and point mutations in the dystrophin gene.  The dystrophin gene is a large 
gene coding for a long protein product that is part of the motor network in muscle cells. 
Disease severity depends on whether the in/del creates a frame shift or remains in frame. 
The frame-shift variants cause a more severe phenotype, because the altered reading 
frame introduces premature termination codons, whereas in frame variants are still 
functional (Prior and Bridgeman 2005).  The dystrophin gene is located on the X 
chromosome in a highly morphogenic region, also known as a mutational “hot spot”.  
Deletions or duplications account for about two-thirds of the cases of DMD and BMD 
with the remainder of the cases accounted for by smaller deletions and point mutations as 
reviewed by Prior and Bridgeman (2005).   
 
Tandem Repeats 
Tandem repeats are categorized into two groups; micro- and mini- satellites.   
Microsatellites can range from 1 to 4 base pairs; single nucleotide, dinucleotide 
trinucleotide and tetranucleotide.  Repeats of units 6 to 64 bases long are minisatellites 
and can span from 100 bp to 10 kb (Jeffries et al., 1985).  Satellites are units from 5 to 
171 bp and repeats can span from 100 kb to several Mb. A mega satellite is a repeat 
composed of units several kilobases long and can span several hundred kilobases.  The 
number of repeats in succession can be polymorphic in the population due to polymerase 
slippage at DNA replication or mismatched recombination during meiosis.   
Microsatellites in the form of simple tandem repeats with the dinucleotide 
sequence [i.e., (dT-dG)n], are interspersed throughout the human genome with 
approximately 50,000 copies present.  They can be highly polymorphic and their 
variability makes them suitable for gene mapping and parentage testing (Litt and Luty 
1989, Weber and May 1989).  They are usually absent from exons of genes because a 
dinucleotide expansion would disrupt the reading frame of the exon in which they 
resided, resulting in a frame shift.  Polymorphism of a dinucleotide repeat in the STAT 6 
gene is associated with allergic diseases (Tamura et al., 2001).  Trinucleotide repeats are 
the most common form responsible for repeat expansion diseases and disorders. 
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Huntington’s disease, a neuronal degenerative disease in humans, is a genetic 
disorder inherited in an autosomal dominant fashion and is caused by an exonic 
trinucleotide (CAG)n expansion.  In the normal population this repeat is highly 
polymorphic ranging in size from 11 to 34 repeats. Huntington’s cases possess 48 or 
more repeats of this trinucleotide.  Expansions of the repeat occur from one generation to 
the next and exhibits “anticipation”, which is an earlier age of onset with each affected 
generation due to increased repeat length. Lack of recombination of the affected 
chromosome and transmission from the father is typical (HDCRG 1993).  Myotonic 
dystrophy 1, DM1, is caused by a trinucleotide CTG expansion in 3’ untranslated region 
of the dystrophia myotonica-protein kinase gene, DMPK; whereas, an intronic 
tetranucleotide CCTG expansion in intron 1 of zinc finger protein 9, ZNF9 is responsible 
for dystrophia myotonica 2, DM2 (Liquori et al., 2001). 
Minisatellites can be highly polymorphic.  A human DNA “fingerprint” was 
purified and cloned in 1986. This 6.3 kilobase long minisatellite contained multiple 
copies of a 37 bp repeat unit. It was found to have 77 different sized alleles containing 14 
to 524 repeats among 79 individuals (Wong et al., 1986).  The human Aggrecan (ACAN) 
gene contains several repeat domains which are recognition sites for the binding of other 
molecules.  Its keratin sulfate attachment domain has 11 repeats of a hexameric amino 
acid sequence. The chondroitin sulfate binding region, CS1, has a highly conserved 
repeat region that translates to the same 19 amino acids repeated 19 times (Doege et al., 
1997).  Larger repeats, which are so big they cytogenetically alter the chromosomes, have 
been identified.  A repeat spanning over 1 Mb of chromosome 15 has been identified. 
The repeat region contains unprocessed partial duplicates of the GABRA5 gene and 
unprocessed duplicates the immunoglobulin heavy chain (IgH) D segment gene and the 
neurofibromatosis type 1 (NF1) gene (Ritchie et al., 1998). 
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Transposable Elements 
The first transposable elements were discovered in maize (McClintock, 1950). 
Transposable elements can be separated into two categories, Class I retrotransposons and 
Class II transposons. Class II elements are DNA transposons which are movable elements 
that are excised from the genome then inserted at a new location.  This family of 
transposable elements includes; Drosophila P elements, Helitrons and Maverick (Richard 
et al.,. 2008).  The Class I elements relocate in a copy and paste  method utilizing RNA 
as the copy which is then reverse transcribed and pasted back into the genome in another 
location.  These elements include long terminal repeats (LTRS), long interspersed nuclear 
elements (LINES), short interspersed nuclear elements (SINES), Dictyostelium 
intermediate repeat sequence (DIRS) elements and Penelope-like elements (PLE).  In the 
horse, ERE1 and ERE2 are two members of the SINE family of transposable elements 
(Gallagher et al., 1999). There are five members of the LINE family of transposable 
elements represented in the horse (Adelson et al., 2010).  
Alu elements of the SINE category are roughly 280 nucleotides long with no 
introns and are the most common transposable elements across the human genome with 
nearly 1 million copies present (Schmid, 1998).  Alu elements are commonly found 
associated with some microsatellites and may play a role in microsatellite expansion or 
transposition within the genome (Arcot et al., 1995). The insertion of Alu elements into 
or near genes can disrupt gene function. Genetic mutations in genes due to insertion of 
Alu elements account for approximately 0.1% of human diseases or disorders including, 
but not limited to; neurofibromatosis, hemophilia, breast cancer, Apert syndrome, 
cholinesterase deficiency and complement deficiency (Deininger & Batzer, 1999).  An 
Alu insertion into exon 5 of the Factor IX gene was found to be the cause of hemophilia 
B in one patient. This insertion interrupted the reading frame of the gene and introduced a 
stop codon within the inserted sequence (Vidaud et al., 1992). 
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Copy Number Variations (CNV) 
When insertions or deletions involve an entire gene, and possibly its promoter 
region, copy number variations arise.  An increased or decreased number of the same 
gene creates a gene dosage effect.  For example, a duplication of the CC chemokine 3-like 
1 (CCL3L1) gene has been found to decrease host susceptibility to infection by HIV.   
The product of this gene is a ligand for the main co-receptor for HIV, the CC chemokine 
receptor 5 (CCR5).  Individuals possessing more copies than the population average of  
two to four copies (depending upon the geographic region/population) for the CCL3L1 
gene have decreased susceptibility to HIV infection.  Individuals with the lowest copy 
numbers for these populations had between 69 and 97% higher chance of getting HIV 
(Gonzalez et al., 2005).  Copy number variations have been found associated with autism 
(Sanders et al., 2011).  A duplication found at a site known for microdeletions, which 
cause Williams–Beuren’s Syndrome, has been found to have the opposite effect of the 
microdeletions, which are known for expressive language, but poor drawing capabilities. 
The patient with the duplication had severe language difficulties, especially with 
expressive language, but had increased drawing capabilities for expressing thoughts 
(Somerville et al., 2005). 
 
Pseudogenes 
Pseudogenes are related to functional genes, but are defective.  Pseudogenes fall 
into two categories; genes that retain the regulatory and intervening sequences and the 
more abundant variety that lacks introns and regulatory sequences.  The latter category, 
known as processed pseudogenes, are the result of reintegration mature mRNA into the 
genome; a process also known as retrotransposition. Processed pseudogenes lack introns 
and other regulatory sequences, have poly A tails and are flanked by direct repeats of 7-
17 base pairs (Vanin, 1985). Pseudogenes can complicate gene discovery with their 
similarities to functional genes. Beta-tubulin is a member of a multi gene family. Four 
sequences are represented in the human genome.  One sequence is the expressed gene 
which yields 1.8 kb and 2.6 kb mRNAs resulting from two different polyadenylation 
sites. The other three members of this family are processed pseudogenes each flanked by 
different short direct repeats; two derived from the 1.8 kb mRNA and the other derived 
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from the 2.6 kb mRNA (Gwo-Shu Lee et al., 1983).  Not all retroposons result in 
pseudogenes. The human phosphoglycerate kinase family includes a functional intronless 
PK2 gene and the pseudogene psi hPgk-1 (McCarrey, 1990). 
Redundancy can be created in a genome when one or several genes or even the 
entire genome is duplicated in its entirety. Segmental duplication can happen during 
unequal “crossing over” resulting in homologous recombination between similar 
sequences.  When complete genes are included in the duplicated sequence, the gene 
duplication events can lead to growth of gene paralogues.  Resulting gene families 
contribute to copy number variation and increased gene dosage effect.  When mutations 
collect in one or more of a gene’s duplicates, they may be silenced into a pseudogene or 
become a unique gene with a new distinct or specialized function. Approximately 40% of 
the coding regions in the olfactory receptor cluster on human chromosome 17 are taken 
up by pseudogenes (Sharon et al., 1999).   
 
Inversions 
Inversions are DNA segments that have been flipped compared to their relative 
position in the genome.  In heterozygotes they have been noted to suppress recombination 
of the region in which they reside.  An inversion will cause phenotypic effects if it 
disrupts a gene or regulatory region that controls expression of a gene or genes.  
Many cases of Hemophilia A were found to be caused by an inversion.  
Hemophilia A is an X-linked disorder caused by various mutations in the factor VIII gene 
(Lakich et al., 1993).  Approximately 43% of individuals with this disease possess an 
inversion involving this gene due to chromosomal homologous recombination beginning 
mainly in male germ cells (Antonarakis et al., 1995). In horses, a 43Mb inversion near 
the KIT gene has been found responsible for the Tobiano coat pattern (Brooks et al., 
2007). 
 
Translocations 
Mismatching during meiosis can lead to translocations where one segment of a 
chromosome is removed from its normal location and moved to a different position on 
that chromosome or to another chromosome.  Large translocations are usually 
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microscopic in size and categorized as cytogenetic defects.  Smaller translocations have 
to be characterized on a molecular level. Autosomal translocations, characterized 
cytogenetically, have been associated with repeated early embryonic loss in horses (Lear 
et al., 2008). Translocations of genetic material from the X or Y chromosomes can have 
developmental effects on sex determination (Villagómez  et al., 2011). Examples of 
human diseases caused by translocations include acute myeloid and acute lymphoblastic 
leukemia.  In these diseases the Myeloid/Lymphoid (MLL) gene has been implicated 
because it spans the breakpoint of an 11q23 translocation (Thirman et al., 1993). 
 
Methylation/Imprinting 
The methylation status of any genomic region can determine whether that region 
is packaged tightly into heterochromatin and transcriptionally silenced or whether it is 
more loosely packed into euchromatin exposing it to molecular factors for its active 
transcription.  The methylation status of some regions or genes can be maternally or 
paternally predetermined at conception, a phenomena known as imprinting.  The hybrid 
offspring of horses and donkeys are known as hinnies (product of female donkey male 
horse) and mules (product of female horse and male donkey).  Their physical and 
temperamental differences are suspected to be the result of preferentially expressed 
maternal/paternal genes (Allen et al., 1993). Hinnies tend to be smaller in stature like the 
donkey dam and have longer manes and shorter ears like the horse sire.  Mules tend to be 
taller like the horse dam with longer ears and sparse mane more like the donkey sire.  
Both tend to have temperaments more similar to the sire as well.  In a recent study 
comparing, horses, donkeys, mules and hinnies, it was found that 15 known imprinted 
genes, play a major role in placental development.  These 15 equine imprinted genes 
matched imprinting direction as previously seen in human, mouse, hinny and mule.   The 
five maternally expressed genes included insulin-like growth factor 2 receptor (IGF2R) 
and nucleosome assembly protein 1-like 4 (NAP1L4).  The ten paternally expressed genes 
included Insulin-like growth factor 2 (IGF2) and paternally expressed gene 3 (PEG3).  
An additional 78 paternally biased candidate imprinted genes were also identified (Wang 
et al., 2013).  The different prenatal environments resulting from these differentially 
expressed genes may explain a few of these differences. 
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There are some genes that are dosage dependent and one active copy is all that is 
required for development and life.  Two active copies may result in a disease state.  To 
protect against this, one copy, the mother’s or the father’s (depending upon the gene), is 
silenced by methylation of cytosines in GC rich regions within that genomic area.  These 
genes are inherited from the mother or the father in a silenced or active state known as 
imprinting.  The insulin like growth factor 2 (IGF-2) gene is affected by tissue specific 
maternal imprinting in mice. Both alleles are transcriptionally active in the choroid 
plexus and leptomeninges, but only the paternal IGF 2 allele is active in all other 
embryotic tissues (DeChiara et al., 1991).  Genes may also be silenced or activated by 
increased or decreased methylation due to environmental cues or point mutations that 
alter the GC content of a region. The changes to DNA methylation or histone acetylation 
as a result of exposure to carcinogens is implicated in some cancers by the mechanism of 
increased methylation of DNA repair genes or deacetylation of histones allowing 
reactivation of developmental genes, both of which may possibly also be a catalyst for 
increased mutation rate of surrounding DNA or destabilization of nearby microsatellites.  
Excessive methylation throughout a 5' "CG island" region of the pi-class glutathione S-
transferase gene (GSTP1) is associated with human prostate cancer (Lee et al., 1997). 
 
Heterogeneity of Phenotypes 
 Not all phenotypes are the result of single discrete Mendelian variation. There are 
some diseases with well defined phenotypes that are caused by different variations in 
different families or populations, but within the same gene. Alternately, there are diseases 
with similar, yet difficult to distinguish, phenotypes which can be the result of variations 
in different genes that play roles in the same pathway or process.  Severe combined 
immunodeficiency (SCID) is a group of autosomal recessive diseases in people that is 
genetically and phenotypically heterogeneous.  Two of the first phenocopies of SCID 
characterized in the 1970s were purine nucleoside phosphorolase deficiency and 
adenosine deaminase deficiency both of which are inherited in an autosomal recessive 
manner (Giblett et al., 1975, Giblett et al., 1972 and WHO Scientific Group, 1995).  X-
linked forms of SCID are due to mutations in the γ chain of IL-2 receptor (Schwaber and 
Rosen, 1990).  The more rare causes of SCID are the result of MHC class II deficiency, 
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reticular dysgenesis, CD3γ or CD3ε deficiency or CD8 deficiency (Reith et al., 1988, 
Ownby et al., 1976,). There is heterogeneity of variants within the genes responsible for 
each type of SCID.  SCID is a condition in horses and mice, but equine and murine SCID 
are a result of a deficiency in DNA-PK; a gene not implicated in any cases of human 
SCID(Perryman and Torbek 1980, Pla and Mahouy 1991).  
Cystic Fibrosis (CF) is an autosomal recessive disease that is the result of many 
different individual mutations in the CFTR gene. Several of the variations responsible for 
CF and differences between their manifestations of the disease are covered in a review by 
Lommatzsch and Aris (2009).  The CFTR locus was mapped by positional cloning to 
human chromosome 7q in 1989 and was the first genetic disease mapped in this fashion 
(OMIM 1998).  This disease has a broad range of manifestations depending on the 
mutation(s) present in the individual.  Generalized atrophic benign epidermolysis bullosa 
(GABEB) is another autosomal recessive disease responsible for sub-epidermal 
blistering, alopecia, dystrophic nails and dysplastic teeth which is caused by different 
independent mutations in the same gene.  This disease is due to reduced or eliminated 
expression of the collagen17 gene, COL17A1 also known as BPAG2, resulting from 
nonsense mutations, which are genetic variations that introduce premature stop codons 
(PTCs) into a transcript.  A few of the mutations responsible for GABEB are SNPs 
altering an amino acid residue directly to a PTC (Darling et al., 1997).  Another causative 
variation is in the form of a double base deletion which creates a frame shift in the 
reading frame of the resulting RNA creating a PTC downstream of the deletion (McGrath 
et al., 1996).  These variations each cause disease when an individual is homozygous for 
any one, but individuals can also be affected when they are compound heterozygotes 
(Darling et al., 1997).  Fragile-X Syndrome, hemophilia, Duchenne’s and Becker’s 
Muscular Dystrophy and red-green color blindness are other examples of X-linked trait 
with heterogeneity of mutations within a single gene. 
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Complex Genetic Modes of Inheritance 
Many common traits and diseases are not the result of simple Mendelian 
inheritance of a single variant.  These are defined as quantitative traits that result from the 
cumulative action of multiple genes that interact with each other in a biological pathway 
or process.  Causative genes identified in the study of complex traits are known as 
quantitative trait loci (QTLs).  In humans, height clearly has a genetic component but is 
the product of many genes, deduced from early genetic studies over 95 years ago (Galton, 
1886, Fisher, 1918).  Heritability of height is approximately 0.8, meaning it has a very 
strong genetic component, but roughly 20% of height is determined by environmental 
factors (Visscher et al., 2010, Allen et al., 2010).   Hypertension (high blood pressure) is 
a common disorder that is the result of complex polygenic inheritance (Rapp, 1983).  
Hypertension can lead to stroke, heart attack or other forms of cardiovascular disease.  
Cardiovascular disease is the leading cause of death in the world (WHO, 2011).  Initial 
investigations to locate QTLs for hypertension were done crossing hypertensive rat 
strains with normotensive strains then crossing the F1 progeny to produce offspring to be 
tested for segregating marker alleles (Rapp, 1983; Rapp, 1987 and Rapp, 1991). 
 
Milk yield, fat percentage, fat yield, protein percentage and protein yield are 
polygenic traits in dairy cattle.  These traits are the consequence of the interaction of 
multiple genes and are partially affected by environmental factors.  The first statistically 
significant QTLs for milk production in Holstein dairy cattle were mapped to five 
chromosomes implementing interval mapping and “progeny testing” using microsatellites 
(Georges et al., 1995).   
 
Osteochondrosis dissecans (OCD) is a condition in horses where the bone under 
the articular cartilage fails to completely form resulting in tears and fissures in the 
cartilage surface above and can affect any bone/joint surface. It can affect the cartilage of 
any joint, but clinical significance is attributed to joints that affect soundness. 
Heritablility for Osteochondrosis of the hock joint (OC) and palmar/plantar osteochondral 
fragments (POF) was investigated in a study that included 24 Swedish Standardbred 
trotter sire families. This study concluded a heritability of 0.34 for OC and 0.23 for POF 
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(Philipsson et al., 1993).  It is thought that several genes play a role in location and 
severity, as well as its age of onset. There appears to be an increased occurrence of this in 
young horses with rapid growth. This condition is considered to be a complex trait and it 
is believed diet, injury, exercise and genetics all contribute to its development 
(Stromberg, 1979).  Microsatellite based WGAS conducted over the last decade have 
identified 14 quantitatitive trait loci that play a role in OCD, but only a few match 
locations between the different breeds of horse (Distl, 2013).  
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Section IV: Genetic Markers and Maps 
The rediscovery of Mendel’s genetic principles led to investigations for 
Mendelian genetic variation in diverse organisms.  For example, this led to investigations 
of blood groups in animals such as; cow (Ferguson, 1941), pig (Andresen and Baker, 
1964) and horse (Stormont and Suzuki, 1964).  Biochemical and isozyme alleles were 
found to be valuable and potentially polymorphic markers to observe for hereditary 
variation between individuals.   Isoenzyme markers also became useful biochemical 
markers for certain malignancies (Bostick et al., 1978). 
During the 1970s, scientists were sequencing the genes they identified.  Some of 
the first sequencing was accomplished through chemical modification of the DNA and 
cleavage of the modified product at Harvard University (Maxam and Gilbert, 1977).  The 
development of the chain-terminator sequencing method designed by Frederick Sanger at 
Cambridge University was a groundbreaking step in molecular genetics (Sanger and 
Coulson, 1975 and Sanger et al., 1977). Higher sequencing throughput increased the 
discovery rate of polymorphisms in the genome such as SNPs and microsatellites.  
Restriction fragment length polymorphisms, RFLPs, are the result of polymorphisms in 
the genome that introduce or eliminate a cleavage recognition site for restriction 
enzymes.  Restriction enzymes are a special class of bacterial endonucleases that 
recognize specific sequences of nucleotides in double stranded DNA and cause cleavage 
of both strands in a specific place of the recognition site.  Their original function was to 
degrade bacteriophage DNA to restrict its ability to proliferate in the bacteria.  The first 
specific cleavage site was found for the restriction endonuclease Hae I (Kelly and Smith, 
1970).  Sites for these enzymes were some of the first markers used for mapping purposes 
(Botstein et al., 1980).  An initial linkage map of the human genome was developed in 
1989 with 403 polymorphic loci, including 393 RFLPs linked to approximately 95% of 
the genome (Donis-Keller et al., 1987).  Sickle Cell Anemia, an amino acid variant in 
hemoglobin resulting from a single base change, was the first instance of a disease 
phenotype found to be linked to a polymorphism at a restriction site (Kan and Dozy, 
1978). The gene for Huntington’s disease was mapped to chromosome 4 and the region 
where it resided was narrowed considerably using RFLPs (Shoulson and Chase, 1975, 
Gusella et al., 1983, Gilliam et al., 1987).  Restriction sites contain only two alleles, so 
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RFLPs aren’t always sufficiently informative for mapping endeavors. The more 
polymorphic nature of microsatellites made them a new valuable tool for gene mapping 
and parentage testing (Litt and Luty, 1989, Weber and May, 1989).  A second generation 
linkage map was constructed using family segregation analysis, with 813 markers on 22 
autosomes and the X-chromosome spanning regions covering about 90% of the estimated 
length of the human genome (Weissenbach et al., 1992). Over the next two years, the 
human marker map would be expanded to 2,066 markers (Gyapay et al., 1994) 
In 1990, the NIH gene-mapping project, also known as the human genome 
project, was initiated.  What began in 1911 with the assignment of a single gene on the 
X-chromosome became the project of the century in 1990, a 15 year plan with the end 
goal of sequencing the entire 3 billion base pairs of the human genome.  This project, 
which seemed farfetched at its inception, was completed 2 years ahead of schedule in 
2003. A press conference on April 14th of that year and special issues of Nature: Double 
Helix at 50 (April 24, 2003) and Science Building on the DNA Revolution (April 11, 
2003) marked this historic landmark in genetic research. 
The human genome of approximately 3 billion base pairs was sequenced and 
subsequently assembled in 2001 to find that it actually only harbors 20 to 25 thousand 
genes (Venter et al., 2001, International Human Genome Sequencing Consortium 2004).  
To explain human complexity from so few gene products, it is believed that about 70% of 
human genes produce multiple mRNAs from alternate splicing of exons or parts of exons 
(Black, 2003). A single gene can produce multiple mRNA and/or protein products.  Each 
gene product can affect multiple genes upstream and downstream from it or even affect 
its own transcription with positive or negative feedback.  A common phenotype can arise 
from multiple variations in a single gene or from variations in a variety of genes within a 
network.   Different variations in a single gene can play a role in many phenotypically 
different traits or diseases or be the cause of a single disease or phenotype.  Even 
environmental factors can affect gene expression or even result in the introduction of 
variations which lead to disease phenotypes. 
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Genome Sequences and SNP Discovery 
The Human Genome Project ushered in an era of genomics with the development 
of methods and tools to cheaply and rapidly sequence DNA and investigate gene 
expression.  With the advent of the genomics era, the complete genomes of more than 
180 organisms have been sequenced 
(http://www.genomenewsnetwork.org/resources/sequenced_genomes/genome_guide_p1.
shtml).  The genomes of pathogens have been sequenced to aid in the development of 
vaccines and therapies; Neisseria meningitidis, Heliobacter pylori, Mycobacterium 
tuburculosis and Pseudomonas aeruginosa (Pizza et al., 2000; Tomb et al., 1997; Cole et 
al., 1998 and Stover et al., 2000) to name a few. The genomes of model organisms; 
Drosophilia melanogaster (Adams et al., 2000; Myers et al., 2000; Rubin et al., 2000), 
mouse (Asif et al., 2002) and Norway rat (Gibbs et al., 2004) were sequenced to inform 
us about genetics, The genomes of many vertebrates, including cattle (Zimin et al., 2009), 
chickens (Hillier et al., 2004)), dogs (Lindblad-Toh et al., 2005)) and horses (Wade et al., 
2009), were sequenced to inform us about the genome organization of vertebrates relative 
to that of human and mice.  
This surge of DNA sequencing led to discovery and use of SNPs which are, at 
best, only diallelic and often may not be polymorphic in families or even in certain 
populations. However, these are so numerous that finding a polymorphic SNP within a 
region is relatively simple since they occur roughly 1 per 1000 bases.  Genome-wide 
studies identify millions of SNPs from which assays of tens of thousands would provide 
coverage of 20 or more SNPs per centiMorgan.  For example; the low density SNP array 
currently used for the domestic horse includes over 54,000 polymorphic SNPs with 
approximately 54kb between SNPs (McCue et al., 2012).  SNPS can and are used for 
linkage studies, but the large numbers available make them suitable for genome wide 
association studies (GWAS), which have power for the mapping and discovery of genes 
responsible in complex traits and diseases (International Hapmap Consortium, 2007). 
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Nature of Genome Wide Association Studies (GWAS) 
A genome wide association study is a way to investigate genetic associations at a 
population level without families. This is necessary if the trait is rare, samples are 
difficult to acquire or if the mode of inheritance is unclear. The discovery of more than a 
million SNPs and the ability to design and implement a SNP chip to assay thousands of 
SNPS spanning the entire genome at the same time has provided a way to perform 
powerful population level studies.  A genome-wide association study (GWAS) is the 
investigation of thousands of common genetic variants in different individuals in search 
of any variant associated with the trait of interest. It is based on the concept of linkage 
disequilibrium, LD, shown in Figure 1.1. Variations in the genome arise over time.  All 
individuals possessing the variation also share a common set of markers, some of which 
are close enough to the variation that they were passed down together from generation to 
generation. In a GWAS, informative markers in LD with the variant or gene of interest 
will show statistical significance. 
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Figure 1.1: Linkage Disequilibrium Explained. 
This figure shows the emergence of variations over time. The red starburst is a genetic 
variation of interest. This is an example of linkage disequilibrium (LD) between a 
specific variant and nearby markers/variants. The variation of interest is closer in time of 
emergence with the brown marker, but physically closer and in LD with the white 
marker.  This physical proximity reduces the likelihood these two points will be separated 
by recombination during meiosis. 
 
The completion of whole genome sequences and discovery of millions of SNPs 
has made it possible to investigate genetic associations at a population level and without 
involvement of families. This is important in the following cases:  
• The trait is rare and a limited number of affected individuals are available for 
study,  
• The trait is one which is undesirable and breeders will not select or save affected 
offspring, (Indeed, in extreme cases they may be reluctant to identify affected 
offspring as coming from their breeding stock.)  
• The mode of inheritance is unclear, due to genetic complexity or due to 
incomplete penetrance.  
 In such cases, GWASs have proven effective by successfully identifying risk loci 
for disorders such as rheumatoid arthritis, Crohn’s disease, bipolar disorder, 
hypertension, diabetes and many others (Stranger et al., 2011).  GWAS is based on a 
basic population genetics concept, the presence of linkage disequilibrium between genes 
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and markers. Animals which belong to the same breed may share common ancestors 
within 10, 20 and 30 generations spanning 100-300 years.  Genes closely linked in the 
ancestor are unlikely to have been separated by genetic recombination events.  As a 
result, there will be a statistical association between alleles of closely linked loci.  In 
practice, human populations demonstrate linkage disequilibrium between SNPs in 
haplotype blocks that are from 8.8 to 25.2kb (Hinds et al., 2005).  For horses, dogs, and 
cattle, the LD ranges from 1-8 million bases (McCue et al., 2010; Gray et al., 2009 and 
Khatkar et al., 2008).  Therefore, when a genetic trait exists within a population and 
animals with and without that trait are compared, using tens of thousands to hundreds of 
thousands of informative SNPs, statistical associations may be detected.   
 
Marker Maps for Linkage Studies, Especially in the Horse 
 
With the advent of molecular genetics, several types of genetic markers were used 
in early linkage studies.  The two earliest markers used were restriction fragment length 
polymorphisms (RFLPs) and simple tandem repeats (STRs) or microsatellites.  RFLPs, 
were used to develop genetic maps in hybrid plant lines (Tanksley et al., 1989) and for 
domestic animals (Fries and Ruddle, 1989). Microsatellites soon proved even more 
effective than RFLPs since they were more widely distributed throughout the genome 
than STRs and often had multiple loci ensuring that more loci would be informative in 
families (Litt and Luty, 1989; Weber and May, 1989). Linkage maps were developed for 
many of the organisms being studied.  By 1992, a second-generation human linkage map 
was constructed of 814 polymorphic markers including microsatellites and RFLPs which 
covered about 90% of the estimated length of the human genome (Weissenbach et al., 
1992). 
Early studies of genetic markers in horses involved investigations of genetic 
systems useful for parentage testing.   Three autosomal linkage groups were discovered 
prior to the initiation of the Horse Gene Mapping Workshop in 1995. The first linkage 
group included the K blood group locus and the 6-phosphogluconate dehydrogenase 
locus (Sandberg, 1974). The second linkage group consisted of four loci; serum albumin 
locus (Al), tobiano (TO), vitamin D binding protein locus (Gc) and the serum esterase 
locus (Es) (Trommershausen-Smith, 1978; Sanberg and Juneja, 1978; Weitkamp and 
25 
 
 
Allen, 1979). The third linkage group included the A blood group and lymphocyte 
alloantigens (Bailey et al., 1979).  The coat colors chestnut and roan were found to be 
linked to loci Al and Es in the second linkage group (Andersson and Sandberg, 1982).  
Identification of these linkage groups was the beginning of the budding equine marker 
map.  These discoveries were less an effort to make a comprehensive map and more a 
byproduct of genetic investigations. 
In the 1990s, microsatellite DNA markers were identified and found to be suitable 
for parentage testing (Litt and Luty, 1989; Weber and May, 1989). Over the next decade, 
sequencing of equine genes and genomic regions began yielding more and more 
microsatellites to be used in a future equine marker map and well suited for parentage 
testing 
In 1995, a group comprised of 70 scientists from 20 countries gathered to 
collaborate on mapping and sequencing the horse genome.  Publication of the first 
sizeable equine linkage map occurred in 1998 and was comprised of 100 markers in 25 
linkage groups encompassing 18 equine autosomes (Lindgren et al., 1998).  The next 
year, a map was published containing 182 microsatellites and 58 random amplified 
polymorphic DNA (RAPD) markers sorted into 33 linked groups.  Twenty two of the 
groups were assigned to known chromosomes with the remaining 11 groups just 
provisionally placed upon verification by other methods (Shiue et al., 1999).  The first 
linkage maps for horses were reported with 140, 161 and 353 microsatellite markers, 
respectively, by combining of resources from the International equine gene mapping 
workshop culminating in a comprehensive map of 766 markers (Lindgren et al., 1998; 
Guerin et al., 1999; Swinburne et al., 2000 and Penedo et al., 2005).   
While linkage maps were effective at identifying genetic distances between 
polymorphic genetic markers, they did not provide as much information about genes. 
Gene sequences are highly conserved among species and comparative genetic studies 
using cross-species fluorescence in situ hybridization (Zoo FISH) indicated strong 
conservation of genome structure.  Radiation hybrid maps were used to visualize the 
relationship of particular genes and markers across species.  A comparative horse map 
comprised of 4103 markers made up of microsatellites, known genes, and radiation 
hybrids of markers from other species was compiled in 2008 (Raudsepp et al., 2008).  An 
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entire genome reference sequence was still the final goal.  A complete assembled genome 
sequence would be the most complete marker map compiled, with SNPs, microsatellites 
and known genes from comparative maps all easily accessible.  The whole genome of the 
horse was completed in 2006 with the first online reference assembly available in January 
2007.  The final assembly was available in September of that same year.  The manuscript 
detailing sequencing and assembly of the equine genome was published in 2009 (Wade et 
al., 2009).  This publication included characterization of approximately 1 million single 
nucleotide polymorphisms (SNPs), the next tool in genetic discovery.  The discovery of 
large numbers of SNPs spurred the development and implementation of SNP chips for 
equine gene discovery and mapping.  
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Nature of Linkage Studies 
Linkage studies require assembly of families including sires, dams and offspring 
and the use of genetic markers that may be linked to the gene under investigation.  
Linkage means that the gene and genetic markers are present on the same chromosome 
and sufficiently close that genetic recombination will not cause their co-segregation to be 
random (50%).  When the gene marker and the gene are very close, for example, 5 to 10 
cM apart, then small numbers of offspring (20 or less) may be effective in determining a 
statistical proof of linkage.  If the genetic markers are more distant from the gene, for 
example 20-30 cM apart, then a large number of offspring will need to be tested to 
distinguish the linkage relationship from random segregation.  Informative families are 
often difficult to assemble; consequently, it is beneficial to have one or more genetic 
markers that are close to the gene of interest. This is a challenge since we do not know in 
advance where the gene and gene markers lie relative to one another.  The solution is to 
have a large number of genetic markers to assure that at least one will be within 5 to 10 
cM of the gene of interest.  Botstein et al. (1980) suggested that a human linkage map 
with 150 evenly distributed genetic markers would be sufficient to ensure that a gene 
would be within 10 cM of a marker based on the observation of 3000 cM for the human 
gene map.  At the time, it was not possible to select genetic markers which would be 
evenly distributed and the solution was to map a greater number of genetic markers so 
that, by chance, the gene in question would be sufficiently close to a linkage marker.   
 
Family Linkage Studies  
Family linkage studies are applied to search for markers in specific genetic 
regions which co-segregate with the gene of interest from parent to offspring.  This kind 
of study requires assembly of families which include sires, dams and offspring. Genetic 
markers are used which may be linked to the investigated gene. Microsatellites, also 
known as short tandem repeats (STRs), are a valuable resource in this type of study.   
Genetic linkage is based on the concept that genes and markers located near each 
other on a chromosome are inherited together.  The closer genes are to one another the 
less likely they are to be separated during meiosis.  The base pairs which compose the 
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genetic markers, loci and genes are all connected to one another in a linear fashion on 
each chromosome, like beads on a string.  This linear connection can be broken and 
rearranged during meiosis.  At the time of meiosis, the paired chromatids (one half of 
each chromosome received from the parents) are susceptible to recombination between 
them due to crossing over events.  
A linkage map consists of genes and genetic markers shown in relation to one 
another in terms of recombination frequency are calculated as a distance, cM.  A map of 
known markers is an invaluable tool used to discover genes responsible for specific 
phenotypes or diseases.  Linkage mapping is accomplished with a family study where the 
recombination frequencies are calculated with a logarithm (base 10) of odds (LOD) score 
method (Morton, 1955).  The LOD score, represented as Z, compares the probability of 
obtaining the data if the two loci are linked to the probability of obtaining the data if the 
two loci are not linked. A LOD score of +3 shows that the odds are 1000 to 1 that the 
linkage observed did not occur by chance.  LOD is calculated LOD = log10 (1- Θ) NR x ΘR 
/ 0.5(NR+R), where Θ = number of recombinants(R) / number of recombinants (R) + 
number of non recombinants (NR).  
For a dominant, co-dominant or partially dominant trait, mapping is 
straightforward.  A verified heterozygous sire possesses a trait of interest. Assuming that 
markers and genes in proximity to each other will be linked, a search of known markers 
for one that is linked with the phenotype will give an approximate location for the genetic 
region responsible for the trait. The sire will transmit the gene causing the trait of interest 
approximately 50% of the time as shown in Figure 1.2, showing a Punnett square using 
Cream inheritance as the example.  
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Figure 1.2: Incomplete Dominant Punnett Square Example: Cream Dilution. 
Palomino sire’s genotype CR/cr. He will pass on CR 50% of the time. This Punnett 
square uses a palomino dam as well with genotype Cr/cr. This mating would produce 
Cremello 25% of the time, palomino 50% and sorrel undiluted 25%. This example is 
given on the chestnut base color. 
A family linkage analysis is performed with data derived from a sire heterozygous 
for the well-defined dominant trait to be studied and 10 to 20 of his offspring. Ten is an 
adequate number for initial screening sample sets, but 20 or more informative offspring 
may be necessary to achieve statistical significance. Significance is calculated using the 
LOD score method to calculate the probability that two loci are linked. The LOD score is 
calculated as log10 of the Likelihood Ratio (LR): LR = ΘR (1-ΘNR)/0.5N, where the LR is 
the likelihood of association divided by likelihood of no association due to free 
recombination. Therefore the LOD value or Z = log10 ΘR (1-ΘNR)/0.5N, where Θ = 
recombination rate R/ (NR+R), R = number of recombinants and NR = number of 
nonrecombinants.  
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Linkage Analysis: Dominant Traits 
For example: A heterozygous sire tested with alleles A and B for a particular 
microsatellite marker.  This marker would not be considered informative if the sire were 
homozygous for a single allele.  After testing ten of his offspring, five with sire’s trait of 
interest and five without it:  four of the five offspring who share the sire’s trait had allele 
B; the remaining offspring who shared the trait had allele A. Among the five offspring 
not sharing the trait, all five had allele A.  This data is shown below in the bottom half of 
figure 2.6.  In this case, all 10 offspring were informative, meaning there was no 
ambiguity about which genotype they received from the sire.  Offspring are considered 
uninformative if they have the same two markers as the sire, because it is unknown which 
marker they inherited from him. If the genotype of the dam is known as well, then the 
origin of the offspring genotype may be clarified.  Occasionally, even with the dam’s 
genotype, some offspring still may not be informative.  The one offspring with the sire’s 
phenotype bearing allele A is considered recombinant.  This means from 10 offspring 
there is 1 recombinant and 9 nonrecombinants, therefore, R = 1, NR = 9. Plugging them 
into the formula above will give this; LR = (0.11(1-0.1)9/ 0.510) = (0.1*(0.387)/0.000977) 
= (0.0387/0.000977) = 39.62.  Therefore LOD = log10 (39.62) = 1.6. What does this 
mean? Association results are considered to be significant if the Z value is equal to or 
greater than 3. A LOD value of 3 means there is significant evidence for linkage; this 
means the odds are 1000:1 in favor of linkage between loci.  The LOD value for these 10 
offspring was only 1.6.  LOD score values are additive. This means LOD scores for 
different sire families can be added if each individual sire has an inadequate number of 
offspring to attain significance when LOD values of the different families are combined. 
So, if a second family is studied and found to have a LOD score of 1.8, then the 
combined LOD score will be 3.4 and considered statistical evidence for linkage. 
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Linkage Analysis: Recessive Traits 
For a recessive trait, a heterozygote is a carrier (not affected).  Carriers are 
identified by the presence of affected offspring they have produced.  They are expected to 
transmit the gene of interest 50% of the time, but only affected offspring will be 
informative.  Unaffected offspring are un-informative because it is impossible to 
determine the status of carrier/non-carriers for a yet undiscovered variation.  Two or more 
affected offspring per carrier are necessary for effective linkage analysis.  According to 
Hardy-Weinberg equilibrium (HWE), population frequency of the affected allele can be 
calculated using the formula p2 +2pq + q2 = 1, knowing also that p + q = 1, where p = 
dominant wild type allele and q = recessive variant allele. Frequencies of the different 
genotypes are represented by p2, 2pq and q2.  In this population the frequency of lordotic 
horses was 0.04, and if caused by a recessive gene, the frequency of this phenotype is 
represented as q2.   Consequently, the gene frequency for affected allele (q) would be 0.2.    
By subtraction, the normal allele (p) would have a frequency of 0.8.   According to the 
HWE equation, unaffected carriers would be present in a frequency of 2pq or 0.32.  An 
example of population frequencies of genotypes from crosses assuming HWE is given in 
table 1.1. 
 
Table 1.1: Recessive Inheritance Example 
                 Sires 
Dams 
                        p = 
0.8 
                           q = 
0.2 
P = 0.8 pp = 0.64 pq = 0.16 
q = 0.2 pq = 0.16 qq = 0.04 
Population frequency of genotypes occurring in crosses assuming HWE.  Frequencies are 
represented by p2, 2pq and q2. If the frequency of a recessive trait is 0.04 then a 
population frequency of the recessive (q) allele can be calculated to be 0.2 using the 
formula p2 +2pq + q2 = 1. 
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Microsatellites have been successfully used for family studies in horses.  For 
example, genomic position of the silver (Z) locus was found when significant linkage was 
shown between the candidate gene PMEL17 and microsatellite marker TKY284. This 
analysis was accomplished in a family study containing a single sire family that included: 
1 heterozygous Silver stallion, 34 of his offspring and their 29 dams which were not 
silver (Brunberg et al., 2006. The Appaloosa gene leopard complex (LP) was assigned to 
a region of chromosome 1 in the vicinity of two positional candidate genes for LP (pink 
eyed dilution (p) and transient receptor potential cat-ion channel subfamily M. member 
1(TRPM1) using two paternal half sib families containing a total of 47 offspring (Terry et 
al., 2004).  Several possible causative SNPs (6) were identified after target sequencing of 
a 300kb region containing TRPM1 (Bellone et al., 2010).   The genetic locus for Sabino 1 
(SB1), which causes a white spotting pattern, was determined after a successful family 
study involving 3 sires and 27 offspring and 7 dams (Brooks and Bailey, 2005).  The 
genomic location where the Cream (C) gene resides was identified using a family 
consisting of one stallion, 7 mares and 21 offspring (Locke et al., 2002).  The C locus 
was identified after sequencing the positional candidate gene MATP (Mariat et al., 2002). 
Linkage between microsatellite CORO18 and the Grey locus was identified with 7 half 
sib Quarter Horse families including 276 offspring and 128 dams (Locke et al., 2002).  
The mutant locus was later identified as containing a 4.6kb duplication in intron 6 of the 
STX17 gene (Rosengren-Pielberg et al., 2008). 
 
 
 
 
 
 
 
 
 
33 
 
 
When to Use Linkage Analysis and What it Might Miss Relative to GWAS 
Family linkage studies are applied when sufficient family members are available 
for investigation into simple Mendelian traits.  Linkage testing requires minimal marker 
coverage, about one per 10 to 20 cM and minimal sample numbers of 20-50 compared to 
the hundreds to thousands of samples and markers utilized in GWAS.  However, a 
linkage study can still fail to produce results if markers near the region of interest are not 
informative.  This could either be due to parental homozygosity of necessary marker(s) or 
unresolved offspring genotypes.  Even when a study successfully identifies a linked 
marker locus, the locus may not show evidence of association in a population of 
unrelated individuals.  This could be the result locus heterogeneity between family 
groups.  For example, family linkage mapping identified the genetic region for Sabino 
1(Sb1) white spotting pattern in Tennessee Walking Horses (Brooks and Bailey, 2005).  
When to Use GWAS and What it Might Miss Relative to Linkage 
When enough family members cannot be obtained or when a trait has complex 
etiology, GWAS is recommended, as was the case with lavender foal syndrome (LFS).  
LFS is a rare recessive lethal trait found in Egyptian Arabian Horses.  This rarity 
precluded the collection of enough family members to perform a linkage study.  
Therefore, GWAS was performed which successfully identified markers in linkage 
disequilibrium with the trait from 6 affected samples and 30 unaffected relatives (Brooks 
et al., 2010).  
Complex traits are difficult to study by linkage as they are more often attributed to 
many genes with minor effect rather than a single gene(s) with major contribution.  
Minor effects are more readily identified in GWAS case/control population studies that 
provide more power in associations of limited effect on phenotype.  Complex traits can 
be the result of incomplete penetrance due to; gene-gene interactions, environmental 
factors or gene-environment interactions.  There are still disadvantages involved in case-
control study designs compared to family linkage studies.  They offer no internal check 
for genotyping quality. Results for controls may show a departure from Hardy-Weinberg 
Equilibrium (HWE), which could be caused by genotyping error, selective 
breeding/mating practices, negative selection, population stratification or pure chance. 
34 
 
 
The desired reason for departure from HWE would be the genotyped SNP actually plays 
a role in the disease or susceptibility or is in linkage disequilibrium with the causal 
variation.  Other factors that negatively affect outcome include poor genotyping quality 
with missing genotypes and population stratification.  The issue of population 
stratification can be avoided by using a family-based study, as was done in the lordosis 
study discussed in chapter 3.  
The search for the cause of Osteochondrosis dissecans (OCD) has been 
approached from a linkage study standpoint and whole genome association studies with 
mixed results.  Initially, a family linkage study was performed on Hanovarian 
Warmbloods with 14 paternal half sib families in a search for quantitative trait loci (QTL) 
using 172 initial microsatellites and 88 additional ones to refine QTLs. QTLs were found 
on ECA 2, 4, 5 and 16 and chromosome wide significance for QTLs was noted on ECA 
2, 3, 4, 5, 15, 16,, 19 and 21 (Dierks et al., 2007).  GWAS involving South German Cold 
Blood horses found association ECA 18 (Wittwerc et al., 2009).  GWAS/linkage analysis 
was done in Norwegian Standardbred Trotters with 162 horses, 80 cases, 82 controls, 22 
half sib paternal groups.  Two analyses were performed; mixed model analysis and basic 
association test.  Both identified QTLs on the same chromosomes; ECA 5, 10, 27, 28 
(Lykkjen et al., 2010).  GWAS in French Trotters concluded associations with GM 
(severity) ECA13, HM (Hock location) ECA3, 13, 14 and other (other locations) ECA 
13, 15 (Teyssedres et al., 2012).  GWAS investigation of osteochondrosis dissecans in 
Thoroughbred horses found association on ECA3 (Corbin et al., 2012).  These results 
have some similarities but vary more than they agree.  In each study, the testing was done 
on different breeds with different measures and different affected joints considered. The 
variation in results might be attributed to the genetic heterogeneity of the condition as 
well as differing management practices or jobs each horse performed.  Overall, multiple 
loci contributing to OCD have been successfully identified by one or more of the listed 
studies.  A more concise set of parameters regarding the joint affected, severity of lesions 
and age of onset may be beneficial for more consistent results between studies and 
breeds. 
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Section V: Applications of Genetic Tools 
 
The foregoing describes the nature of genetic variation and some examples of 
resulting phenotypes.  When phenotypic variation is apparent within a population, we 
have two major tools for investigation:  linkage studies using families and genome wide 
association studies using individuals selected from a population merely based on 
phenotype.  The discovery of microsatellite DNA markers spanning the horse genome 
during the last 20 years has made possible genome wide linkage studies when families 
are available.   The development of the horse genome sequence and the availability of 
tools to assay tens of thousands of SNPs have made possible genome wide studies in 
populations.  The studies discussed in this dissertation describe the investigation of two 
different types of phenotypic variation in horses that can be investigated using these 
tools. 
 
Champagne Dilution 
The base coat colors of horses are red and black, encoded by the MC1R locus 
(Marklund et al., 1996).  The Champagne dilution gene (CH) has been found in several 
breeds in the United States, notably the Tennessee Walking Horse, and its effect is to 
dilute both the eumelanin (black) and the pheomelanin (red) pigments.  The gene is 
sometimes confused with the effects of the Cream dilution gene (Cr), which only dilutes 
eumelanin. Breeders interested in breeding for this trait need an effective test to 
distinguish the different loci. Since the trait is considered attractive, breeders select for 
these animals and several families were available for study.  This project is the subject of 
Chapter 2.    
 
 
 
 
 
 
 
 
36 
 
 
Genetics Form and Functional Structure: Extreme Lordosis 
Some breeders of American Saddlebred horses are concerned about the 
occurrence of a condition called swayback that was thought to be hereditary. While some 
breeders select against the condition, others do not consider it a serious defect and 
tolerate such horses in their breeding programs.  However, no one advertises the 
condition or actively selects for it. This made it difficult to obtain large and complete 
families segregating for this trait.  Therefore, to investigate the heredity of this condition, 
a genome wide association study was conducted as described in Chapter 3.   
 
 
Copyright © Deborah G. Cook 2014 
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CHAPTER TWO: Champagne Dilution in Horses 
 
Summary 
Champagne coat color in horses is controlled by a single, autosomal-dominant 
gene (CH). The phenotype produced by this gene is valued by many horse breeders, but 
can be difficult to distinguish from the effect produced by the Cream coat color dilution 
gene (CR). Three sires and their families segregating for CH were tested by genome 
scanning with microsatellite markers. The CH gene was mapped within a 6 cM region on 
horse chromosome 14 (LOD = 11.74 for θ = 0.00). Four candidate genes were identified 
within the region, namely SPARC [Secreted protein, acidic, cysteine-rich (osteonectin)], 
SLC36A1 (Solute Carrier 36 family A1), SLC36A2 (Solute Carrier 36 family A2), and 
SLC36A3 (Solute Carrier 36 family A3). SLC36A3 was not expressed in skin tissue and 
therefore not considered further. The other three genes were sequenced in homozygotes 
for CH and homozygotes for the absence of the dilution allele (ch). SLC36A1 had a 
nucleotide substitution in exon 2 for horses with the champagne phenotype, which 
resulted in a transition from a threonine amino acid to an arginine amino acid (T63R). 
The association of the single nucleotide polymorphism (SNP) with the champagne 
dilution phenotype was complete, as determined by the presence of the nucleotide variant 
among all 85 horses with the champagne dilution phenotype and its absence among all 97 
horses without the champagne phenotype. This is the first description of a phenotype 
associated with the SLC36A1 gene. 
 
 
[Most of the work described in this chapter was published 2008 PloS Genetics 4(9): 
e1000195. doi:10.1371/journal.pgen.1000195] 
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Introduction 
 Many horse breeders value animals with specific genetic variation in coat color 
variations.   Several genes are known which diminish the intensity of the coloration and 
are phenotypically described as “dilutions”. Two of these are a result of the Cremello and 
Silver loci.   The molecular basis for Cremello is the result of a single base change in 
exon 2 of MATP gene (Membrane Associated Transporter Protein), also referred to as 
SLC45A2 (Solute Carrier family 45 member A2), on ECA21 (Mariat et al., 2002 and 
Locke et al., 2001).  This change results in the replacement of a polar acidic aspartate 
with a polar neutral asparagine in a putative transmembrane region of the protein coded 
for by this gene (Locke et al., 2001 and Brunberg et al., 2006).   The Cremello gene has 
an incomplete dominant mode of expression.  In its heterozygous form it dilutes only 
pheomelanin (red pigment) whereas homozygosity for CR results in extreme dilution of 
both pheomelanin and eumelanin (black pigment) (Adalsteinsson, 1974).   
 The Silver dilution is the result of a missense mutation of PMEL17 
(Premelanosomal Protein) on ECA6. The base change causes replacement of a cytosolic 
polar neutral arginine with non-polar neutral cysteine in PMEL17 (Brunberg et al., 2006).   
In contrast to CR, the Silver locus is fully dominant and affects only eumelanin causing 
little to no visible change in the amount of pheomelanin.  The change in eumelanin is 
most apparent in the mane and tail where the black base color is diluted to white and gray 
(Bowling, 2000).   
The coat color produced by the CH locus is similar to that of CR in that both can 
cause dilution phenotypes affecting pheomelanin and eumelanin.  However, CH differs 
from CR in that; 1) It dilutes both pheomelanin and eumelanin in its heterozygous form 
and 2) Heterozygotes and homozygotes for CH are phenotypically difficult to distinguish.  
The homozygote may differ by having less mottling or a slightly lighter hair color than 
the heterozygote.  Figure 2.1 displays images of horses with the three base coat colors 
chestnut, bay and black and the effect of the CH locus on these colors.   
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Figure 2.1: Effect of Champagne Gene action on Base Coat Colors. 
A) Chestnut – Horse only produces red pigment.  B) Chestnut diluted by Champagne.  C) 
Bay – Black pigment is held to the points (eg. Mane, tale, and legs) allowing red pigment 
produced on the body to show.  D) Bay diluted by Champagne   
E) Black – Red and black pigment produced, red masked by black 
F) Black diluted by Champagne 
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Figure 2.2 shows CH foals are born with blue eyes, which change color to amber, 
green, or light brown and pink “pumpkin” skin which acquires a darker, mottled 
complexion around the eyes, muzzle, and genitalia as the animal matures (Sponenberg 
2003).   In contrast, foals with one copy of CR also have pink skin at birth but their skin 
is slightly darker and becomes black/near black with age.  Indeed, the existence of a gene 
responsible for a separate dilution was not readily apparent until the discovery that some 
horses exhibit a dilution phenotype, without CR.  The champagne phenotype is found 
among Tennessee Walking Horses, Quarter Horses and several other breeds from the 
United States. Here we describe family studies that led to mapping the gene and 
subsequent investigations of candidate genes leading to the identification of a genetic 
variant that appears to be responsible for the Champagne dilution phenotype.   
The purpose of this study was to uncover the molecular basis for the champagne 
hair color dilution phenotype in horses. Here, we report a DNA base substitution in the 
second exon of the horse gene SLC36A1 (Solute Carrier family 36 member A1) that 
changes an amino acid in the transmembrane domain of the protein from threonine to 
arginine. The phenotypic effect of this base change is a diminution of hair and skin color 
intensity for both red and black pigment in horses and the resulting dilution has become 
known as champagne. This is the first genetic variant reported for SLC36A1 and the first 
evidence for its effect on eye, skin, and hair pigmentation. So far, no other phenotypic 
effects have been attributed to this gene. This discovery of the base substitution provides 
a molecular test for horse breeders to test their animals for the Champagne gene (CH).  
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Figure 2.2: Champagne Eye and Skin Traits  
A, B and C) Eye and skin color of foals 
D and E) Eye color and Skin mottling of adult horse 
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Materials and Methods 
Horses 
Three half-sibling families, designated 1, 2 and 3, were used for mapping studies.   
Family 1 consisted of a Tennessee Walking Horse (TWH) stallion, known heterozygous 
at the Champagne locus (CH/ch), and his 17 offspring out of non-dilute mares (ch/ch).  
Family 2 consisted of an American Paint Horse stallion (CH/ch) and his 11 offspring out 
of non-dilute (ch/ch) mares. Family 3 consisted of a TWH stallion (CH/ch), 25 offspring 
and their 10 non-dilute dams (ch/ch) and 1 dilute (buckskin) dam (ch/ch, CR/cr).  
Pedigrees of the three sire families are provided in Figure 2.3.   
 
 
 
Figure 2.3: Sire and Offspring Pedigrees 
Males are represented with squares and females with circles.  Individuals exhibiting the 
Champagne Dilution phenotype are represented by solid colored symbols while non-
Champagne individuals are represented with uncolored symbols. There were no dams 
included for sire families 1 or 2, as sire family 3 was the only family with dams available. 
In sire family 3, the sire is number 7 in line I which includes him and the dams.  Dam’s 
offspring are ones falling between her and the sire or between her and the dam beside her 
proximal to the sire. For example: Offspring number II1 in sire family 3 is the product of 
dam I1 and sire who is I7. Offspring II2 and II3 in sire family 3 are from dam I2 and sire 
who is I7. 
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To investigate the distribution of the gene among dilute and non-dilute horses of 
different horse breeds, 97 unrelated (within a single generation) non-champagne horses 
were chosen from stocks previously collected and archived at the MH Gluck Equine 
Research Center. These horses were from the following breeds: TWH (20), 
Thoroughbreds (TB, 35), American Paint Horses (APHA, 32), Pintos (5), American 
Saddlebreds (ASB, 2), one American Quarter Horse (AQHA), one pony, and one 
American Miniature (AMH) Horse.  
 Hair and blood samples from horses with the champagne dilution phenotype were 
submitted by owners along with pedigree information and photographs showing the 
champagne color and characteristics of each horse. Samples were collected from the 
following breeds (85 total): American Miniature Horse (9), American Cream Draft (1), 
American Quarter Horse (27), American Paint Horse (13, in addition to the family), 
American Saddlebred (2), Appaloosa (1), ASB/Friesian cross (1), Arabian crossed with 
APHA or AQHA horses (3), Missouri Foxtrotter(4), Mule (2), Pony (1), Spanish 
Mustang 1), Spotted Saddle Horse (1), Tennessee Walking Horse (19), in addition to the 
families).  
 
Color Determination  
To be characterized as possessing the champagne phenotype, horses met at least 
two of the three following criteria: 1) mottled skin around eyes, muzzle and/or genitalia, 
2) amber, green, or light brown eyes, or 3) blue eyes and pink skin at birth (Sponenberg 
2003).  This was accomplished by viewing photo evidence of these traits or by personal 
inspection.  Due to potential confusion between phenotypes of cream dilution and 
champagne dilution, all DNA samples from horses with the dilute phenotype were tested 
for the CR allele and data from those testing positive were not included in the population 
data.   
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DNA Extraction 
DNA from blood samples was extracted using Puregene whole blood extraction 
kit (Gentra Systems Inc., Minneapolis, MN) according to its published protocol. Hair 
samples submitted by owners were processed using 5-7 hair bulbs according to the 
method described by Locke et al. (2002). The hair bulbs were placed in 100 µl lysis 
solution of 1X FastStart Taq Polymerase PCR buffer (Roche), 2.5 mM MgCl2 (Roche), 
0.5% Tween 20 (JT Baker, Phillipsburg, NJ) and 0.01 mg proteinase K (Sigma-Aldrich, 
St Louis, MO) and incubated at 60 ◌۫C for 45 minutes, followed by 95 ◌۫C for 45 min to 
deactivate the proteinase K. 
 
Microsatellite Genome Scan 
The genome scan was done in polymerase chain reaction (PCR) multiplexes of 3 
to 6 microsatellites per reaction. The 102 microsatellite markers used are listed in Table 
2-1. Primers for these microsatellites were made available in connection with the USDA-
NRSP8 project (Guérin et al., 1999).  Two additional microsatellites were used; TKY329 
[18] was selected based on its map location between two microsatellites used for genome 
scanning (UM010 and VHL209) and COOK007 was developed in connection with this 
study based on DNA sequence information from the horse genome sequence V2 as 
viewed in the UCSC genome browser (Kent et al., 2002) in order to investigate linkage 
within the identified interval.   Primers for COOK007 were designed using Primer 3 
software accessed online (Forward, 5’- 6FAM-CATTCCAAACACCAACAACC - 3’), 
(Reverse, 5’ – GGACATTCCAGCAATACAGAG – 3’) (Rozen and Skaletsky, 1998).  
Microsatellite PCR reactions were done in multiplexes, with anywhere from 3 to 
six microsatellites included per reaction. They were grouped according to annealing 
temperature and color differences of the dye probes; VIC (green), 6FAM (blue), NED 
(yellow). Multiple markers using the same color probe could be used if the product sizes 
differed by enough base pairs. PCR product from each assay is filtered to remove excess 
fluorescent labeled primers and dried down to be rehydrated with formamide for analysis 
in the ABI 310 sequencer. For example: microsatellite LEX020, from table 2.2, has seven 
known alleles. The fluorescently labeled product from PCR will fall in the approximate 
size range from 198 to 222 base pairs long. Preferentially, the sire will test for two 
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differently sized alleles in or near this size range in order for the marker to be 
informative. Each offspring will produce results for two alleles as well. If the offspring 
has one or both alleles matching only one allele the sire possesses, then that offspring is 
deemed informative. The results for that individual are uninformative if it has two alleles 
which match both of the sire’s alleles. 
Amplification for fragment analysis was done in 10 µl PCR reactions using 1X 
PCR buffer with 2.0mM MgCl2, 200 μM of each dNTP, 1 µl genomic DNA from hair 
lysate, 0.1U FastStart Taq DNA polymerase (Perkin Elmer) and the individual required 
molarity of each primer from the fluorescently labeled microsatellite parentage panel 
primer stocks at the MH Gluck Equine Research Center. Samples were run on a PTC-200 
thermocycler (MJ research, Inc., Boston, MA) at a previously determined optimum 
annealing temperature for each multiplex. Capillary electrophoresis of product was run 
on an ABI 310 genetic analyzer (Applied Biosystems). Results were then analyzed using 
the current version of STRand microsatellite analysis software 
(http://www.vgl.ucdavis.edu/informatics/STRand/). 
The initial multiplex scans were conducted on a subset of samples from Family 3 
which included sire 3, five non-champagne offspring, and five champagne offspring.   
When the microsatellite allele contribution from the sire was not informative, (e.g. the 
sire and offspring had the same genotype), dams from family 3 were typed to determine 
the precise contribution from the sire.  When the inheritance of microsatellite markers in 
family 3 appeared to be correlated with the inheritance of the CH allele, then the 
complete families 1, 2 and 3 were typed and the data analyzed for linkage by LOD score 
analysis (Morton 1956).  Final genotypes and LOD scores for marker COOK007 are 
given in figure 2.4.  
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Figure 2.4: Allele Results and LOD Scores for Microsatellite COOK007 
Among the three sire families. Sires A, B and C correspond to sires 1, 2 and 3 in that 
order from previous pedigree image. The numbers 324 and 332 are the length of each 
allele represented by the microsatellite amplified by the COOK007 primer pair. This 
microsatellite is on Equine Chromosome 14 at ~25.6 Mb. The data suggests this 
microsatellite is in linkage disequilibrium with the Champagne allele.  The first line of 
each box identifies the sire family and the microsatellite primer ID.  The second line is 
the pair of alleles the heterozygous champagne sire possesses for that microsatellite. The 
third line represents the champagne offspring and the allele they received from the sire. 
The fourth line is non-champagne offspring and the allele they received from the sire. 
The fifth line contains the offspring (champagne and non-dilute) whose genotype was 
ambiguous and sires contribution could not be determined.  The sixth and last line is the 
manually calculated LOD score for each family’s data.  
 
 
 
 
 
 
 
 
 
47 
 
 
Table 2.1: Microsatellites Used for Genotype Screening  
Marker Chromosome Alleles Size Dye 
Annealing 
Temp 
Optimal     
concentration        
(uM) 
AHT21 01 8 199-215 VIC 58 0.09 
COR100 01 7 212-230 VIC 56 0.15 
HMS15 01 11 207-245 6FAM 56 0.6 
VIAS-H34 01 7 144-160 VIC 58 0.7 
ASB8 01 8 138-164 VIC 58 0.08 
LEX020 01 7 198-222 6FAM 58 0.12 
ASB41 01 6 156-168 NED 58 0.3 
NVHEQ100 01 7 197-217 6FAM 58 0.1 
ASB18 02 12 196-213 6FAM 58 0.15 
A-14 02 10 220-248 VIC 58 0.8 
COR065 02 9 280-292 NED 58 0.3 
ASB17 02 17 93-125 6FAM 58 0.1 
UM007 02 18 122-176 VIC 58 0.05 
COR033 03 9 222-254 VIC 58 0.2 
ASB23 03 7 187-213 VIC 58 0.1 
UCDEQ437 03 8 167-193 NED 58 0.1 
SGCV23 04 8 221-233 VIC 56 0.6 
ASB22 04 9 155-177 NED 58 0.1 
COR089 04 10 282-304 NED 58 0.1 
LEX004 05 6 282-300 NED 58 0.15 
LEX069 05 7 248-262 NED 56 0.6 
LEX034 05 6 252-262 NED 58 0.05 
TKY28 06 7 280-364 NED 58 0.15 
COR088 06 7 283-297 NED 58 0.4 
COR070 06 12 279-307 NED 58 0.2 
NVHEQ82 06 6 133-147 VIC 58 0.01 
VIAS-H7 07 12 116-146 6FAM 58 0.3 
COR004 07 6 297-319 NED 58 0.5 
COR003 08 8 195-215 6FAM 58 0.15 
COR056 08 10 194-220 6FAM 58 0.2 
LEX023 08 12 233-257 VIC 58 0.15 
ASB14 08 9 118-136 6FAM 58 0.05 
HTG8 09 7 185-197 6FAM 56 0.6 
ASB4 09 6 128-140 VIC 58 0.7 
COR008 09 12 251-277 NED 58 0.12 
UM037 09 7 108-124 6FAM 58 0.2 
ASB6 10 8 185-212 6FAM 58 0.6 
COR048 10 10 178-186 NED 58 0.3 
ASB9 10 9 67-113 6FAM 58 0.3 
NVHEQ18 10 15 119-161 VIC 58 0.06 
COR020 10 7 162-176 NED 58 0.2 
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Table 2.1: cont… 
 
Marker 
 
Chromosome Alleles Size Dye 
Annealing 
Temp 
Optimal     
concentration        
(uM) 
SGCV24 11 10 125-141 VIC 56 0.5 
SGCV13 11 5 169-179 NED 58 0.7 
LEX068 11 7 162-174 NED 58 0.12 
SGCV8 12 8 126-143 VIC 58 0.2 
SGCV10 12 6 179-187 NED 56 0.6 
AHT17 12 11 123-147 6FAM 58 0.1 
COR058 12 12 218-244 VIC 58 0.1 
ASB37 13 6 132-146 VIC 58 0.04 
COR069 13 8 273-287 NED 58 0.13 
VHL047 13 4 134-150 VIC 58 0.05 
COR002 14 5 235-243 VIC 58 0.05 
UM010 14 7 112-126 6FAM 58 0.05 
VHL209 14 6 91-105 6FAM 58 0.2 
AHT16 15 7 130-153 VIC 58 0.2 
COR014 15 12 149-164 VIC 58 0.04 
B-8 15 8 88-110 6FAM 56 0.1 
COR075 15 9 202-220 6FAM 58 0.07 
HMS20 16 8 116-140 6FAM 58 0.25 
L15.2 16 9 147-165 VIC 58 0.07 
LEX056 16 7 218-234 VIC 58 0.08 
I-18 16 9 93-119 6FAM 58 0.05 
COR007 17 9 163-177 NED 58 0.04 
LEX055 17 7 216-232 VIC 58 0.15 
NVHEQ79 17 7 175-197 6FAM 58 0.08 
TKY19 18 9 147-173 NED 56 0.04 
COR096 18 8 315-329 NED 58 0.2 
LEX054 18 10 170-190 NED 58 0.08 
COR092 19 6 191-203 6FAM 58 0.1 
LEX036 19 8 148-170 NED 58 0.05 
LEX073 19 11 249-277 NED 58 0.15 
LEX052 20 7 208-214 VIC 58 0.05 
LEX071 20 7 192-211 6FAM 58 0.12 
HMS42 20 0 132-140 VIC 58 0.07 
UM011 20 11 167-187 NED 58 0.1 
COR073 21 8 187-205 6FAM 58 0.1 
LEX037 21 4 196-202 6FAM 56 0.07 
SGCV16 21 5 154-194 NED 58 0.12 
HMS47 22 7 203-215 6FAM 58 0.17 
HTG21 22 7 131-143 VIC 58 0.08 
COR016 22 7 184-203 6FAM 58 0.12 
COR055 23 9 240-270 NED 58 0.1 
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Table 2.1: cont… 
 
Marker 
 
 
Chromosome Alleles Size Dye 
Annealing 
Temp 
Optimal     
concentration        
(uM) 
LEX074 24 10 155-175 NED 58 0.15 
       
COR024 24 6 214-226 VIC 58 0.05 
COR061 24 11 197-227 6FAM 58 0.1 
COR018 25 7 251-283 NED 58 0.1 
NVHEQ70 26 7 192-208 6FAM 58 0.08 
COR071 26 8 188-210 6FAM 58 0.05 
A-17 26 8 102-118 6FAM 58 0.15 
COR017 27 12 241-267 VIC 58 0.15 
COR031 27 7 210-224 VIC 58 0.08 
COR040 27 8 282-300 NED 58 0.25 
UCDEQ425 28 8 236-250 VIC 58 0.1 
COR027 29 7 231-255 VIC 56 0.12 
COR082 29 7 199-233 VIC 58 0.4 
L12.2 29 10 136-156 VIC 58 0.05 
LEX025 30 7 152-168 VIC 58 0.04 
LEX075 30 8 144-164 6FAM 58 0.04 
COR038 31 4 210-214 VIC 58 0.1 
AHT33 31 8 151-167 VIC 58 0.15 
UM038 X 7 120-144 6FAM 58 0.2 
LEX022 X 7 110-124 6FAM 58 0.12 
The microsatellites on equine chromosome 14 are highlighted in green. The first column 
is the microsatellite name based upon lab location which identified it. The second column 
is the chromosome on which the microsatellite is located. The third column shows the 
number of alleles possible. The fourth column gives the size spectrum for the alleles, 
given in base pairs. The fifth column is the fluorescent dye label for that primer set. The 
sixth column is the optimal annealing temperature for PCR of that microsatellite. The last 
column is the optimal primer concentration for successful PCR.  
 
 
 
 
 
 
 
 
 
 
50 
 
 
Sequencing 
PCR template for sequencing was amplified in 20 µl PCR reactions using 1X 
PCR buffer with 2.0 mM MgCl2,  200 μM of each dNTP, 1 µl genomic DNA from hair 
lysate, 0.2U FastStart Taq DNA polymerase (Perkin Elmer) and 50 nM of each primer. 
Exon 2 of gene SLC36A1 was sequenced with the following primers: Forward (5’-CAG 
AGC CTA AGC CCA GTG TC-3’) and Reverse (5’-GGA GGA CTG TGT GGA AAT 
GG-3’) at an annealing temperature of 57 ◌۫C.  Additional primers used to sequence the 
other exons are listed in Table 2.2.  Template product was quantified on a 1% agarose 
gel, then amplified with BigDye Terminator v1.1 cycle sequencing kit according to 
manufacturer’s instructions (Applied Biosystems, Foster City, CA), cleaned using Centri-
Sep columns (Princeton Separations Inc., Adelphia, NJ), and run on and ABI 310 genetic 
analyzer (Applied Biosystems). Six samples were initially sequenced: 2 suspected 
homozygous champagnes (based on production of all champagne dilution offspring when 
bred to at least 10 non-dilute dams), 2 heterozygotes, and 2 non-dilute horses. The results 
were analyzed and compared by alignment using Vector NTI Advance 10.3 software 
package (Invitrogen Corporation, Carlsbad, California). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
51 
 
 
Table 2.2: Primers Used for Exon Screening 
Part 1 - Primer sequences for the sequencing of horse SPARC 
Exon 
# Forward Primer (5’-3’) Reverse primer (5’-3’) 
1 TCAGGATTGAAAGGGAACTG ATCTCCACCCAAAAGTCTGC 
2 CGAGTTTGGCATCTTCTTGC AGGTCTGGGAATCAATCAGG 
3 CACGCCTTTTCAGCTTGAC AATTCATGTTCCCCAGAGTCC 
4 GCTCTCCTAAATGCTGATTGC CATCTCCACCTTCTTTTCGTG 
5 GGAGCACAAABAGTGGGTTC GTGGAAGAGATTTGCCCAAG 
6 AGCCACTGTGCCAAGGTC GAGGGGAAGTCTGTGTCCTG 
7 CTTTTGTGCATGAGATGCTG GGAGCAGTGAAGGCTGCTG 
8 ATTGCACATCGTCTCCTTCC GAGTGAGTGCTAATGCTTGAGG 
Primer sequences for the sequencing genomic exons of horse SLC36A1 
Exon 
# Forward Primer (5’-3’) Reverse primer (5’-3’) 
1 AAGCGCCTGTCTGTCTCTTC CTCTTCCTCAGCACCAGCTT 
2 CAGAGCCTAAGCCCAGTGTC GGAGGACTGTGTGGAAATGG 
3 ATCCCAGGAGCCTCTGTTCT GAAGCGTTAAGCCAACAGGA 
4 CAGCTGCTCAGCATCACAG CAAAGCAGGAACAGCCCTTA 
5 CTCCTGCCATTCCAGTCTTG AAGGCTCAGTGTGTGAACGA 
6 AACCCAGCTCAGACAGTTGG CCAGAGACCTTTGGCAATGT 
7 TTTGTGCATGCTCCAACATT GTCAAGTCCTCGTGCAAGGT 
8 CTTATCGCAGGAGGCAGAAC GTCCCACATGGGTAACAAGG 
9 TATCGTGGAGCTGGTTGTGT TTCTCTGCACCATCTGGACA 
10 CTTGCAGTGAGAGACAGGTTATTC TGGGGAACATACAGCGGT 
Primer sequences for the sequencing genomic exons of horse SLC36A2 
Exon # Forward Primer (5’-3’) Reverse primer (5’-3’) 
1 CAGAGCCTGCTAAGGCACAC TTTTCCTCAGCTGCACAATG 
2 GACTGTGAGAAGGCCAGGAG GCTTGTGGAGGCCACTCTAA 
3 AAAAGGGCTTGGAAACCAGT AGCAGAACCTCGCCTTAGGT 
4 CTGCCACAGTGTTCTTTCCA CACCCTGTTGCTGGAGGTAT 
5 GGGACAGAAATGGAAACGAC CCTTGAGGACAGGTCCAAGA 
6 CACCCTAACTCGCTGAGACC ATAAAAGGCTCTGCCCACTG 
7 TCCTCTGGCTCTTTGGTTGT AGGCCAGACGTTGCTTTCT 
8 CCTTTCACCCATCAATGGAC TAGCCTTGAGTCCCCATCAC 
9 CTGCTCTGACTCCCTCTTGG CTGGTTCCTGACCATCCTTC 
10 GTCTAAGCCTGGGATGATGC TCGTAGCTGGTGAATGCTTG 
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Reverse Transcription (RT-PCR) 
 RT-PCR was performed in 25 µl reactions using a Titan One Tube RT-PCR Kit 
(Roche) according to enclosed protocol.  The primers used are listed in section 3 of Table 
S4. RNA from different tissues of non-dilute horses was used to acquire partial cDNAs 
containing the first two exons for SLC36A1, first three exons SLC36A2 and first 4 exons 
of SLC36A3. The cDNA acquired was sequenced and the resulting sequences were 
verified for their respective genes with a BLAT search using the equine assembly v2 in 
ENSEMBL (http://www.ensembl.org/Equus_caballus/index.html) genome browser. RT-
PCR was also performed utilizing RNA extracted from skin, kidney and testes of non-
dilute animals currently in lab stocks. SLC36A1 cDNA was produced from the skin and 
blood using 50 ng RNA per reaction. SLC36A2 cDNA was produced from testes using 1 
mRNA per RT-PCR reaction then following up with a nested PCR for shorter product. 
SLC36A2 cDNA was produced from skin using 50 ng mRNA per RT-PCR reaction. 
Nested PCR was not necessary. SLC36A3 cDNA was produced from testes using 1 ug 
mRNA per reaction. 9 µl of initial reaction was visualized on a 2% agarose gel to check 
for visible bands of product. When product was not initially detected an additional 20 µl 
PCR was performed in reactions as outlined above using 5 µl of RT product in the place 
of hair lysate per reaction. Detected product was then sequenced with the protocol listed 
above. Sequences were then used in a BLAST search using equine genome assembly 2 
on ENSEMBL genome browser to verify the correct cDNA was amplified. 
 
Custom TaqMan Probe Assay 
A Custom TaqMan® SNP Genotyping Assay (Applied Biosystems) was designed 
for c.188C/G SNP in filebuilder 3.1 software (Applied Biosystems) to test the population 
distribution of the SLC36A1 alleles. A similar assay was also designed to test for the 
cream SNP. These assays were run on a 7500HT Fast Real Time-PCR System (Applied 
Biosystems).  All dilute horses tested for SLC36A1 variants were concurrently tested for 
SLC45A variants.   Horses testing positive for CR alleles were not used in the dataset to 
avoid any confusion over the origin of their dilution phenotype. 
 
 
53 
 
 
Results 
 
Linkage Analyses 
Table 2.3 summarizes the evidence for linkage of the CH gene to a region of 
ECA14.  The linkage phase for each family was apparent based on the number of 
informative offspring in each family.   Recombination rates (θ) were calculated based on 
the recombination rate for all families.  Four microsatellites showed significant linkage to 
the CH locus; VHL209 (LOD = 6.03 for θ = 0.14), TKY329 (LOD = 3.64 for θ = 0.10), 
UM010 (LOD =5.41 for θ = 0.04) and COOK007 (LOD = 11.74 for θ = 0.00)   Most 
notably, no recombinants were detected among 39 informative offspring between the CH 
and COOK007 microsatellite locus.  
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Table 2.3: Linkage Analysis between the Champagne Dilution gene and Microsatellite 
Markers UM010, COOK007, TKY329 and VHL209. 
   alleles Sire contribution Statistics 
Family (CH) microsatellite a/b N1 a+ a- b+ b- 
LOD 
score Θ2 
3 (+/-) UM010 124/108 23 14 0 0 9 5.41   
                 Σ= 5.41 0.04 
                      
1 (+/-) COOK007 332/334 14 10 0 0 4 4.21   
2 (+/-) COOK007 332/334 8 4 0 0 4 2.41   
3 (+/-) COOK007 332/324 17 8 0 0 9 5.12   
                 Σ= 11.74 0 
                      
1 (+/-) TKY329 117/139 15 10 2 0 3 1.92   
2 (+/-) TKY329 111/137 9 5 1 0 3 1.34   
3 (+/-) TKY329 117/139 18 7 0 1 10 3.64   
                 Σ= 6.9 0.1 
                      
1 (+/-) VHL209 95/93 13 4 1 1 7 1.49   
2 (+/-) VHL209 91/93 12 4 2 1 5 0.46   
3 (+/-) VHL209 95/93 24 10 1 1 12 4.08   
                 Σ= 6.03 0.14 
The microsatellites are given in the third column. The first column shows the sire 
families with data for each microsatellite. The second column gives the sire status which 
is heterozygous CH with [+] designating the champagne allele and [–] designating the 
non-champagne allele he carries. The fourth column gives the base pair size for the sire’s 
alleles for that microsatellite which have been designated allele [a] and allele [b] for the 
data in columns 6-9. Column 5 is the number of informative offspring for that sire on that 
microsatellite. Column 6 is the number of champagne offspring possessing the [a] allele 
and column 7 is the number of non-champagne offspring possessing the [a] allele. 
Columns 8 and 9 show the number of champagne offspring and non-champagne 
respectively possessing the [b] allele. The tenth column is the manually calculated LOD 
score for each sire family for that microsatellite. The sum of LOD scores for all families 
for each microsatellite is given below the LODs as Σ=. 
1. N = the number of informative meiosis 
2. Θ = recombination frequency between that microsatelite and the champagne gene for 
all families, combined 
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Figure 2.5 identifies the haplotypes for offspring showing recombination between 
the genetic markers and the CH locus.  Table 2.4 exhibits the microsatellite haplotype 
obtained for all individuals tested.  The CH locus maps to an interval between UM010 
and TKY329 with microsatellites.  No recombinants were detected among 39 informative 
offspring between the CH and COOK007 locus. 
 
 
 
 
Figure 2.5: Recombinant Haplotypes  
Linear relationship from top to bottom between the microsatellites, phenotype, and 
genotype of recombinant offspring is shown here, with yellow denoting phenotype when 
coloring block of individual and hypothesized association coloring allele blocks. The [a] 
alleles represent the speculated paternal champagne genotype and [b] alleles represent the 
paternal non-champagne genotype. The marker column gives the approximate genomic 
location for each marker on equine chromosome 14. 
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Table 2.4: Haplotype Data for 3 Families From Figure 2.3 Pedigree Chart 
SIRE 1 
Sire 1 Color Sex UM010   COOK007   TKY329   VHl209 
I-1 CH Sire 124 124  332 334  117 139  93 95 
II-1 ch female -- --  334 338  117 127  87 93 
II-2 ch female 108 124  324 334  139 139  93 95 
II-3 ch male 116 124  332 334  117 127  85 95 
II-4 ch male -- --  334 338  127 139  87 93 
II-5 ch female 122 124  334 338  137 139  85 93 
II-6 CH male 122 124  -- --  -- --  93 95 
II-7 CH male 110 124  332 342  117 123  93 95 
II-8 CH male -- --  332 332  117 137  95 95 
II-9 CH male 122 124  332 338  117 137  85 95 
II-10 CH male 122 124  332 338  117 137  85 95 
II-11 CH female 116 124  -- --  -- --  93 95 
II-12 CH female -- --  332 338  117 135  93 95 
II-13 CH male -- --  332 338  117 137  87 95 
II-14 CH female -- --  332 332  117 137  87 95 
II-15 CH male -- --  324 332  117 135  87 95 
II-16 CH male -- --  332 338  117 127  87 93 
II-17 CH female -- --   332 338   117 127   87 95 
 
SIRE 2 
Sire 2 Color Sex UM010   COOK007   TKY329   VHl209 
I-1 CH Sire -- --  332 334  111 137  91 93 
II-1 CH female -- --  332 338  111 139  87 93 
II-2 CH female -- --  332 332  111 139  91 101 
II-3 CH female -- --  332 332  111 139  91 93 
II-4 CH female -- --  -- --  111 139  87 91 
II-5 CH female -- --  332 334  117 137  87 91 
II-6 ch male -- --  334 338  111 137  93 95 
II-7 CH male -- --  330 332  111 139  87 91 
II-8 ch male -- --  334 338  137 139  93 95 
II-9 ch female -- --  324 334  137 139  87 93 
II-10 ch male -- --  332 334  111 127  87 91 
The allele designations are the base pair lengths of the amplified microsatellite alleles. 
Sire family 3 was the only one with dams included. Each heterozygous champagne sire is 
listed first for each family and is in purple. For family of sire 3 the dams are listed below 
the sire in pink with their respective offspring immediately below them. Champagne 
offspring are in tan and non-champagne are in light blue. The genotypes for each 
offspring derived from the sire are colored in tan and blue depending on their inferred 
association with the champagne allele from sire.  
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Table 2.4: cont… 
SIRE 3 
Family 3 Color Sex UM010   COOK007   TKY329   VHl209 
I-7 CH Sire 108 124  324 332  117 139  93 95 
                         
I-1  ch Dam 108 124  324 338  127 139  85 93 
II-1 ch male 108 108  324 324  139 139  93 93 
I-2  ch Dam 108 124  324 338  127 139  85 85 
II-2 ch male 108 124  324 338  127 139  85 93 
II-3 CH male 124 124  332 338  117 127  85 95 
I-3  ch Dam 122 124  332 338  127 127  85 93 
II-4 CH male 124 124  332 332  117 127  85 95 
II-5 CH male 124 124  332 338  117 127  85 95 
II-6 ch male 108 122  324 332  127 139  93 93 
I-4  ch Dam 108 108  324 324  139 139  85 93 
II-7 ch female 108 108  324 324  139 139  85 93 
I-5  ch Dam 116 124  338 338  127 127  85 93 
II-8 ch female 108 116  324 338  127 139  93 93 
I-6  ch Dam 118 122  324 332  137 139  85 85 
II-9 ch female 108 122  324 332  137 139  85 93 
II-10 CH female 118 124  324 332  117 139  85 95 
II-11 CH male 118 124  324 332  117 139  85 95 
II-12 ch male 108 118  324 324  139 139  85 93 
I-8  ch Dam -- --  -- --  -- --  -- -- 
II-13 ch female 108 108  324 324  139 139  93 93 
I-9  ch Dam 120 124  334 338  133 137  85 85 
II-14 CH male 108 124  332 338  133 139  85 93 
I-10  ch Dam 108 114  324 342  139 139  93 93 
II-15 CH male 108 124  324 332  117 139  93 95 
II-16 ch female 108 114  324 342  117 139  93 95 
I-11  ch Dam 124 124  332 338  137 139  85 85 
II-17 CH male 124 124  332 332  117 139  85 95 
II-18 ch male 124 124  324 332  137 139  85 93 
I-12  ch Dam 108 116  324 332  133 139  93 95 
II-19 CH female 108 124  324 332  117 139  93 95 
I-13  ch Dam 108 114  324 342  139 139  93 93 
II-20 ch female 108 114  324 342  139 139  93 93 
I-14 ch Dam 122 122  324 332  117 127  85 95 
II-21 CH female 122 124  324 332  117 117  95 95 
II-22 CH male 122 124  332 332  117 127  85 95 
II-23 CH female 122 124   332 332   117 127   85 95 
Color legend: Purple = Sire, Pink = Dam, Tan = champagne phenotype (tan data = sire’s 
CH associated allele), Red = ambiguous call 
 
58 
 
 
Candidate Genes 
Candidate genes were selected on the basis of proximity to the marker COOK007 
and genes previously characterized as influential in the production or migration of any 
pigment cells.  SPARC [Secreted protein, acidic, cysteine-rich (osteonectin)] was located 
closest at approximately 90kb downstream from COOK007 and implicated in migration 
of retinal pigment epithelial cells in mice (Sheridan et al., 2002).  All 9 exons of SPARC 
were sequenced. Multiple single nucleotide polymorphisms (SNPs) were found but all 
caused synonymous mutations and will not be discussed further in this report.  
SLC36A1, A2 and A2 were also proximal to this marker. SLC36A family members 
are solute carriers and other solute carrier families have previously been found to play a 
role in coat color.  SLC36A1 was the second most proximal gene to COOK007 and is 
located less than 250kb downstream from COOK007. SLC36A2 and SLC36A3 are coded 
for on the plus strand of DNA and are approximately 350 k and 380 k downstream, 
respectively from COOK007. A2 and A3 have been found to be expressed in a limited 
range of tissues in humans and mice (Bermingham and Pennington, 2004). 
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RT-PCR 
RT-PCR (reverse transcription-polymerase chain reaction) was used to determine 
if SLC36A1, SLC36A2 or SLC36A3 were expressed in skin. SLC36A1 and SLC36A2 were 
expressed in skin and their genomic exons were sequenced. SLC36A3 is normally only 
found expressed in testes of other organisms and was not detected in equine skin.  
Therefore, it was not investigated for the presence of SNPs.  Results for RT-PCR of these 
three genes are shown in Figure 2.6 and primers used are shown in Table 2.6.   
 
 
 
Figure 2.6: RT-PCR Product Results for SLC36A1, A2 and A3. 
A) RT-PCR results for SLC36A1, showing mRNA is present in blood and skin of both 
dilute horses and lab stock non-dilutes. B) RT-PCR results for SLC36A2 verifying its 
expression in skin of lab stock non-dilute horses. C) RT-PCR results for SLC36A3 
verifying its expression only in testes with no mRNA detectible in skin of lab stock non-
dilute horses. (Faint bands observed above 400 bp on gel C were sequenced and did not 
show homology to SLC36A3.)   
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Table 2.5: Primer Sequences for Reverse Transcription and Sequencing of Partial 
cDNAs from mRNA 
 
 
Gene 
 
 
Forward Primer (5’-3’) 
 
 
Reverse primer (5’-3’) 
 
Product   
(bp) 
 
Exons 
Included 
SLC36A1 ACCAGCGGTTTGGG
GAAA 
ACGGCCACGATGCCCATC
A 
 
169 
 
1-3 
 
SLC36A2 
(outer 
long) 
 
AAGCGTCATGCCCG
TGACAAAGAGTGCG 
 
GTGGCAGAAGCGCTGGGC
ACACCTG 
 
 
348 
 
 
1-3 
SLC36A2 
(outer 
short) 
 
GCCCGTGACAAAGA
GTGCG 
 
AAGCGCTGGGCACACCTG 
 
334 
 
1-3 
SLC36A2 
(nested) 
 
ACCTCAAACTGGAC
CTCAGG 
 
ATGCCTGCGTTCCTCACA 
 
208 
 
2-3 
 
 
SLC36A3 
 
TTGGAAGGGACTAC
AACAGTGAG 
 
GGTTTCGAGGCTGTACAT
CATG 
 
 
350 
 
 
1-4 
 
 
Sequencing 
All 9 exons of SPARC were sequenced. Three SNPs were found in exons but none 
showed associations with the champagne phenotype.  SLC36A2 was sequenced with 
discovery of 9 SNPs in exons.  None of the SNPs showed associations with CH.  These 
SNPs and all other variations detected during the course of this work are described in 
Table 2.6.   
SLC36A1 was sequenced. Only one SNP was found; a missense mutation 
involving a single nucleotide change from a C to a G at base 76 of exon 2 (c.188C>G) 
(Figure 5). These SLC36A1 alleles were designated c.188[C/G], where c.188 designates 
the base pair location of the SNP from the first base of SLC36A1 cDNA, exon 1  (Figure 
2.7).  Sequencing traces for the partial coding sequence of SLC36A1 exon 2 with part of 
the flanking intronic regions for one non-champagne horse and one champagne horse 
were deposited in GenBank with the following accession numbers respectively: 
EU432176 and EU432177.  This single base change at c.188 was predicted to cause a 
transition from a threonine to arginine at amino acid 63 of the protein (T63R).  
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Figure 2.7: Genomic Alignment between Homozygous Champagne, Non-dilute, and 
Horse Genome Assembly 
Allignment is flanked by cut out electropherogram reading of sequencing data for one 
homozygous champange horse and one homozygous non-champagne horse. Reading 
frame is marked by alternating colors of codons, which code for specific amino acids 
which will make up the resulting protein. The bottom of this figure is a diagram of 
SLC36A1 highlighting the identified SNP in exon 2 with the sequence and gene layout as 
given by Ensembl genome browser equine assembly v2. Blue blocks of gene layout are 
exons and red boxes are the 5′ and 3′ UTRs. The purple star denotes the location where 
the variant associated with champagne was identified. 
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Table 2.6: Sequence Variations Detected 
Gene Location 
Base 
Position 
within 
location Variation Type  5' flank 3'flank  residues 
SPARC In 1-2 1353 A>G   ATG 
GAAT
CTCC
AG   
    1365 C>T   
GAATC
TCCAG 
GAGC
TGCT
CTCC   
                
SPARC  Ex 2 60 C>T syn 
GGCTG
AGGTG
TC 
GAGG
TACG
TGGG Cys>Cys 
                
SPARC  In 2-3 157 G>A   
TGCGT
ATTCC
CA T   
    561 C>T   
AAGCC
TCCCC 
CAGT
CTTC
ACCC   
                
  SPARC In 3-4 87 C>T   
TTCTG
TGAGG
TT 
CCTC
CCAA
GGGA   
    1397 G>A   
AAGG
ATTGG
TCT 
GATT
GGGT
TGGG   
                
SPARC  Ex 4 69 T>C mis 
CAGTC
CCATG
TG 
GTGT
GCCA
GGAC Cys>Arg 
                
SPARC  In 4-5 1827 C>T   
AAAG
GTGCG
AAA 
CCTG
TGCTT
TGC   
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Table 2.6: cont… 
Gene Location 
Base 
Position 
within 
location Variation Type  5' flank 3'flank  residues 
SPARC  In 5-6 19 G>C   
CTTTT
CCTTG
GGC 
CTTCT
GGGC
TTC   
    49 C>A   
CGAGG
AGAG
ACC 
CTGA
ACTG
ACGC   
    78 A>G   
GCTGG
CTGTG
CC 
CCCC
C   
    2181 A>G   
ACCTT
GGGCG
GG 
AGAG
TCAG
GGTC   
SPARC  In 6-7 645 T>C   
AGTCT
CCCTG
GA 
GCTTT
GTCA
CAG   
SPARC  Ex 7 51 A>G syn 
TGGAG
ACCAC
CC 
GTGG
AGCT
GCTG Ser>Gly 
  SPARC In 7-8 95 T>G   
GGTAG
GCTCA
CT 
GATA
TGGT
CAGA   
SLC36A
1  Ex 2 76 C>G mis 
GCAAC
ATTGG
CA 
AGGA
CTCCT
GGG 
Thr 
>Arg 
SLC36A
2  5’UTR 
 - 89 
from 
Start C> del 
GCTGC
TGAGA 
GGGG
TTTGC
ACT   
SLC36A
2  In 2-3 9 G>C   
CTGGT
AAGA
AGG 
GCTG
CCGC
AGGT   
SLC36A
2  Ex 6 45 C>T syn 
TTACA
A 
GAGA
CAGT
GATT Tyr>Tyr 
SLC36A
2  In 6-7 1339 T>C   
ATTCA
GGTCT
AC 
GTCA
GAAT
ACTC   
    1308 T>A   
TAAAG
GAGCT
CA 
ACAT
GCTT
CGAG   
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Table 2.6: cont… 
Gene Location 
Base 
Position 
within 
location Variation Type  5' flank 3'flank  residues 
SLC36A
2  Ex 9 94 C>T syn 
CCTCT
ACGTC
TT 
GGCA
TCCT
GTGC Trp>Trp 
    155 G>A syn 
ATCGT
CCCCT
TC 
CTGT
CTCC
CGCG
C Ser>Ser 
                
  
SLC36A
2 In 9-10 23 T>G   
TCAGC
CAGAT
GG 
GAAG
GATG
GT   
    33 T>G   
GAAG
GATGG ?   
  
SLC36A
2 Ex 10 50 T>G mis 
CCTCT
CCCTG
GT 
GGCT
CCAT
GAGC Trp>Gly 
    64 G>C mis 
GCTCC
ATGAG
CA 
CAGC
GCCC
TGGC Cys>Ser 
  
 
   67 G>C mis 
CCATG
AGCAC
CA 
CGCC
CTGG
CCCT Cys>Ser 
   227 A>G syn 
TCTGA
TCCAG
CC 
ACAG
ACCA
TCTC Ser>Ser 
   265 C>T mis 
CCACC
ATTTT
CA 
TCAG
TGAG
AATG Ser>Phe 
    269 G>C mis 
GATTT
TCACT
CA 
TGAG
AATG
GTGC Cys>Ser 
Types of variants found within exons classified as; mis = missense, syn = synonomous. 
The base position given within location refers to exons/introns.  
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Protein Alignment 
Figure 2.8 shows the alignment of the protein sequence encoded by exons 1 and 2 
of SLC36A1 for seven mammalian species with sequence information from Genbank 
(horse, cattle, chimpanzee, human, dog, rat and mouse).  The alignment was performed 
using AllignX function of Vector NTI Advance 10 (Invitrogen Corp, Carlsbad, 
California) and demonstrates that this region is highly conserved among all species.  At 
position 63, the amino acid sequence is completely conserved among these species, with 
the exception of horses possessing the champagne phenotype.  This replacement of 
threonine with arginine occurs within a putative transmembrane domain of the protein 
(Boll et al., 2003).   
 
 
 
Figure 2.8: Seven Species Protein Sequence Alignment for SLC36A1 Exons 1 and 2. 
The R in red is the amino acid replacement associated with the Champagne phenotype. 
 
 
Population Data 
The distribution of c.188G allele among different horse breeds and among horses 
with and without the champagne phenotype was investigated.  Table 2.7 is a compilation 
of the population data collected via the genotyping assay. All dilute horses (85) not 
possessing the CR gene, tested positive for the c.188G allele with genotypes c.188C/G or 
c.188G/G.  No horses in the non-dilute control group (97) possessed the c.188G allele.  
The horses used for the population study were selected for coat color and not by random 
selection; therefore measures of Hardy-Weinberg equilibrium are not applicable and were 
not calculated.  
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Table 2.7: Results for TaqMan Genotyping of c.188 Locus 
                                  Champagne (CH/CH or CH/ch)    Non-Dilute (ch/ch, cr/cr) 
Horse Breeds G/G G/C C/C Total 
American Cream Draft 
American Miniature Horse 
American Quarter Horse 
American Paint Horse 
American Saddlebred 
Appaloosa 
Kentucky Mountain 
Part Arabian 
Pinto 
Pony 
Missouri Foxtrotter 
Mule 
Spanish Mustang 
Spotted Saddle Horse 
Tennessee Walking Horse 
Thoroughbred 
 
Total 
0 
0 
1 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
3 
0 
 
4 
1 
9 
26 
13 
2 
1 
1 
3 
0 
1 
4 
2 
1 
1 
16 
0 
 
81 
0 
1 
1 
32 
2 
0 
0 
0 
5 
1 
0 
0 
0 
0 
20 
35 
 
97 
 
1 
10 
28 
45 
4 
1 
1 
3 
5 
2 
4 
2 
1 
1 
39 
35 
 
182 
First column contains the horse breeds tested. Second column is for individuals 
homozygous for champagne locus. Third column contains champagne heterozygotes . 
Fourth column has nondilutes negative for champagne alleles. G is the actual champagne 
DNA allele and C is the non-dilute wild type allele. 
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Discussion 
 Family studies showed linkage of the gene responsible for the champagne dilution 
phenotype within a 6cM region on ECA14 (Penedo et al., 2005) (Table 1).  Based on the 
Equine Genome Assembly V2 as viewed in the ENSEMBL genome browser 
(http://www.ensembl.org/Equus_caballus/index.html), this region spans approximately 
2.86 Mbp (Kent et al., 2002).  Within this region, four candidate genes were investigated; 
one was selected based on known effects on melanocytes (eg. SPARC), the other three 
were chosen for their similarity to other solute carrier genes previously shown to 
influence pigmentation (eg, SLC36A1, A2, and A3). While SNPs were found within the 
exons of SPARC, none were associated with CH. Of the other 3 candidate genes, only 
SLC36A1 and SLC36A2 were found to be expressed in skin cells. Therefore, the exons of 
those two genes were sequenced. A missense mutation in the second exon of SLC36A1 
showed complete association with the champagne phenotype across several breeds. 
While SNPs were found for SLC36A2, none showed associations at the population level 
for the champagne dilution phenotype. 
This data is the first demonstration for a role of SLC36A1 in pigmentation. 
Orthologous genes in other species are known to affect pigmentation. For example, the 
gene responsible for the cream dilution phenotypes in horses, SLC45A2 (MATP), belongs 
to a similar solute carrier family. In humans, variants in SLC45A2 have been associated 
with skin color variation (Graf et al., 2005)  and a similar missense mutation 
(p.Ala111Thr) in SLC24A5 (a member of potassium-dependent sodium-calcium 
exchanger family) is implicated in dilute skin colors caused from decreased melanin 
content among people of European ancestry (Lamason et al., 2005).  The same gene, 
SLC24A5 is responsible for the Golden (gol) dilution as mentioned in the review of 
mouse pigment research by Hoekstra (Hoekstra, 2006). 
We propose that the missense mutation in exon 2 of SLC36A1 is responsible for 
the champagne dilution phenotype. While this study provides evidence that this is the 
mutation responsible for the champagne phenotype, the proof is of a statistical nature and 
a non-coding causative mutation cannot be ruled out at this point. SLC36A1, previously 
referred to by the name PAT1 (proton/amino acid transporter 1) in human and mouse 
(Chen et al., 2003), is a proton-coupled small amino acid transporter located and most 
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active in the brush border membranes of intestinal epithelial cells. This protein, also 
known as lysosomal amino acid transporter 1, LYAAT1, was first identified in rat brains 
(Sagne et al., 2001).  SLC36A1 is a symporter that facilitates the coupled transport of H+ 
and select amino acids from both intracellular and extracellular proteolysis. It functions 
in the membrane of lysozomes of brain neurons and the apical membrane of intestinal 
epithelial cells. This function is coupled to the V-type H+ ATPase in lysosomes and with 
Na+/H+ exchanger in the intestinal epithelial cells, which both provide the gradiant which 
drives transport of amino acids to the cytosol (Boll et al., 2003).  LYAAT1/SLC36A1 is 
localized in the membrane of lysozomes and the cell membrane of post-synaptic 
junctions. In lysozomes it allows outward transport of protons and amino acids from the 
lysozome to the cytosol (Wreden et al., 2003).  During purification and separation of 
early-stage melanosomes LAMP1/SLC36A1 is found in high concentrations in the 
fraction containing stage II melanosomes (Kushimoto et al., 2001).  Perhaps SLC36A1 
plays a role in transitions from lysozome-like precursor to melanosome. Since 
organellular pH affects tyrosine processing and sorting (Watabe et al., 2004), an amino 
acid substitution in this protein may affect cytosolic pH by inhibiting the proper flow of 
protons from lysozomes and, therefore, the ability to process tyrosine properly. There 
must be an increase in pH, before tyrosinase can be activated. The cytosolic pH gradient 
must be maintained for proper sorting and delivery of other proteins required for 
melanosome development (Watabe et al., 2008).  Thus, the pH gradient of the cell may 
be altered by this mutation. 
It is hypothesized that disruption of the protein structure by replacement of a non-
polar transmembrane residue with a polar residue results in loss of function for this 
protein.  This is shown here using a figure depicting the topology of the SLC36A1 gene 
originally published by Boll et al (2003). We modified the figure with horse amino acids 
overlaying the first two exons with the suspected CH variation shown in red (Figure 2.9).  
This image shows the transmembrane location of variation and its vicinity to the 
conserved histidine residues which are necessary components of the substrate recognition 
site for this transporter.  The polar residue would negatively affect the structure of this 
transmembrane region and the regions of the protein flanking it, potentially disrupting the 
substrate recognition site.   
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Figure 2.9: First Two Exons of SLC36A1 of the Horse Overlaid on Mouse Topology 
The residue differences between horse and mouse are overlaid in blue and CH variation T 
– R is highlighted in red.  The beginning and end of the 2 exon segment are denoted by 
blue arrows. 
 
 
 
 
Further investigation into this gene/protein product is necessary to elucidate its 
role in pigmentation.  The transport properties could be compared between wild type and 
SLC36A1 and the CH variant using the two-electrode voltage clamp technique in a flux 
study similar to the one by Boll et al. to compare the amino acid uptake rates of 
SLC36A1and SLC36A2 (Boll et al., 2002).  Alternatively, cell cultures containing wild 
type and CH variant melanosomes could be compared for  processes related to melanin 
synthesis and any differences in the ability to transfer melanosomes to keratinocytes.  In 
another approach, copies of SLC36A1 CH variant could be immunofluorescently labeled 
and transfected into other cell lines to identify any change in cellular localization.   
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 This variant, discovered in association with a coat dilution in the horse, is the first 
reported for the SLC36A1 gene.  The phenotype resulting from this mutation, a reduction 
of pigmentation in the eyes, skin and hair, illustrates previously unknown functions of the 
of SLC36A1 protein product.  Furthermore, now that a molecular test for champagne 
dilution is established, the genotyping assay can be used in concert with available tests 
for cream dilution and silver dilution to clarify the genetic basis of a horse’s dilution 
phenotype.  This will give breeders a new tool to use in developing their breeding 
programs whether they desire to breed for these dilutions or to select against them.  
 
Copyright © Deborah G.Cook 2014 
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CHAPTER THREE: Genetics of Extreme Lordosis in American Saddlebred 
Horses 
 
Summary 
Extreme lordosis, also called swayback, lowback or softback, can occur as a 
congenital trait or as a degenerative trait associated with aging. In this study, the 
hereditary aspect of congenital extreme lordosis was investigated using whole genome 
association studies of 20 affected and 20 unaffected American Saddlebred (ASB) Horses 
for 48,165 (SNPs). A statistically significant association was identified on ECA20 
(corrected P = 0.017) for SNP BIEC2-532523. Of the 20 affected horses, 17 were 
homozygous for this SNP when compared to seven homozygotes among the unaffected 
horses, suggesting a major gene in this region with a recessive mode of inheritance. The 
result was confirmed by testing an additional 13 affected horses and 166 unaffected 
horses using 35 SNPs in this region of ECA20 (corrected P = 0.036). Combined results 
for 33 affected horses and 287 non-affected horses allowed identification of a region of 
homozygosity defined by four SNPs in the region. Based on the haplotype defined by 
these SNPs, 80% of the 33 affected horses were homozygous, 21% heterozygous and 9% 
did not possess the haplotype. Among the non-affected horses, 15% were homozygous, 
47% heterozygous and 38% did not possess the haplotype. The differences between the 
two groups were highly significant (P < 0.00001).  The region defined by this haplotype 
includes 53 known and predicted genes.  Exons from three candidate genes, TRERF1, 
RUNX2 and CNPY3 were sequenced but distinguishing SNPs were not found. The 
mutation responsible for extreme lordosis may lie in other genes or in regulatory regions 
outside exons. This information can be used by breeders to reduce the occurrence of 
extreme lordosis among their livestock. This condition may serve as a model for 
investigation of congenital skeletal deformities in other species. 
 
 
[Most of the work described in this chapter was published in 2010 Animal 
Genetics 41(Suppl. 2), 64–71. doi:10.1111/j.1365-2052.2010.02108.x] 
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Spinal Developmental Variations 
During vertebral development different spinal variations from the norm can occur. 
The three major congenital forms of spinal malformation are extreme 
lordosis/hyperlordosis, kyphosis and scoliosis. The most commonly manifested spinal 
deformities studied in humans are congenital scoliosis, adolescent idiopathic scoliosis 
and Scheuermann's kyphosis. Adolescent idiopathic scoliosis (AIS) is characterized by a 
lateral spinal curvature of at least 10 degrees that occurs between age 10 and the point of 
skeletal maturity (Ward et al., 2010). Historically, finding the genetic cause for such 
deformities has been challenging. In humans, cases of known hereditary spinal 
malformations are rare (Winter et al., 1983). In an extended family study of AIS, the 
higher risk within the families was attributed to polygenic inheritance (Ward et al., 2010).  
Even with the polygenic etiology for AIS, one genetic risk variant near LBX1 on human 
chromosome 10 has been identified by whole genome association study (WGAS) 
(Takasha et al., 2011).Scheuermann's kyphosis is a result of uneven growth of the 
thoracic vertebrae resulting in wedge shaped vertebrae and increased kyphotic curve of 
the spine. No particular genetic cause is yet known, but it is believed to be polygenic 
(Fotiadis et al., 2008). 
 
Lordosis 
Lordosis, specifically the dorsal to ventral concave curvature of the thoracic and 
lumbar region of the spine, is normal and healthy in most mammals.  However, extreme 
lordosis is associated with pathology in horses (Rooney & Pickett 1967; Rooney, 1969).  
This condition is also known in horses as swayback, lowback or softback.  Rooney & 
Robertson (1996) noted that variable degrees of lordosis seem to be common in certain 
lines of American Saddlebred horses. Figure 3.1 shows the characteristic conformation 
for a horse with lordosis (Figure 3.1 top) and a normal horse (Fig. 3.1middle).  A familial 
aspect was suspected but not established in previous work.  A study of extreme lordosis 
among Saddlebred horses led Gallagher et al. (2003) to devise a method to measure the 
extent of lordosis and to characterize the variation found among horses in this breed. 
Based on this study, a threshold for considering horses to have the condition was defined, 
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and 5% of 294 horses were considered affected. Studies of affected families suggested, 
but did not prove, a recessive mode of inheritance. 
In our experience, breeders are of mixed opinions regarding this trait. Extremely 
lordotic horses have not been routinely identified as experiencing pain, and some horses 
with this trait have performed well. Most breeders regard the condition as a conformation 
defect and avoid breeding stock with this condition. Identifying the genetic 
determinant(s) for this condition would provide breeders with the opportunity to better 
understand the genetics of the trait and use that information in their selection programs. 
Traditionally, family studies have been most useful to identify the genetic 
locations for hereditary traits in horses such as the tobiano white spotting pattern, equine 
combined immunodeficiency disease and cream coat color dilution (Trommershausen-
Smith 1978; Bailey et al., 1997; Locke et al., 2001).  However, while horses with 
extreme lordosis are not uncommon, breeders avoid mating animals they believe likely to 
produce affected horses. Consequently, family studies are difficult. However, with the 
advent of the horse genome sequence and the availability of dense arrays of single-
nucleotide polymorphisms (SNPs) for whole genome association (WGA) studies, 
population studies can be used to investigate the genetics of traits in horses (Wade et al., 
2009).  The purpose of this study was to determine whether a hereditary component 
contributes to the lordotic trait in American Saddlebred (ASB) horses and, if so, to 
identify the location of genes responsible for this trait. 
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Figure 3.1:Characteristic Conformation Differences Between the Presence and Absence 
of Extreme Lordosis. 
Horses on top and bottom exhibit extreme lordosis. Horse in the middle is consider 
nonlordotic and has a level topline. 
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Materials and Methods 
Phenotypic Assessment of Lordosis 
Phenotypic assessment of lordosis was based on the measurement of back contour 
(MBC) (Gallagher et al., 2003).  Two points are chosen on the horse’s back, one at the 
top of the withers (the highest point of the dorsal spineous process in the region of 
thoracic vertebrae T2-T3) and one on the point of the rump (the highest point on top of 
the horse’s hips).  The shortest distance between those points was measured in 
centimeters and designated “A”.  Next, the distance along the contour of the back was 
measured in centimeters and designated “B”.  MBC was calculated as the difference 
between “A” and “B”.   Figure 3.1c and 3.2 illustrate the points of measurement on a 
horse exhibiting extreme lordosis.   
 
 
Figure 3.2: Calculating MBC. 
Long Back Length – Short Back Length = MBC 
 
Horses Measured for MBC 
Measurements and tissue (hair or blood) samples for ASB horses used in this 
study came from a sample set of 749 American Saddlebred horses collected from private 
and commercial farms in and around Kentucky.  The average age was 7.1 years and 
ranged from 1 month to 29 years old.  All Saddlebred horses used in the Illumina and 
Sequenom assays were selected from among this group.  
 
 
 
 
Short Back Length 
B A 
Long Back 
Length 
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Horses for Illumina Assay 
For the genome scan using the Illumina Equine SNP50 Chip, 40 ASB horses were 
selected, based on their lordosis phenotype.  Twenty horses were selected based on 
having an MBC > 8.0 centimeters and 20 were selected based on having MBC < 5.0 cm.  
The control group included 19 half-siblings for horses in the affected group to reduce the 
chance of population substructure producing spurious associations.    
 
Horses for Sequenom Assay 
A total of 426 horses were selected for a 35 SNPs located in the genomic region 
suggested by the WGA study.  Three horses were tested in duplicate to control for the 
quality of the testing.  Twilight, the thoroughbred horse used for the whole equine 
genome sequencing, was also tested for quality control of known SNPs located in the 
genomic region suggested by the WGA study.  Among the ASB horses, 33 (including the 
20 original cases) had values for MBC of 7.0 or greater, 287 had MBC <7.0 cm and 106 
were parents, siblings or offspring of lordotic horses.  The relatives were tested to assist 
with haplotype determination.    
 
DNA Extraction 
DNA was extracted from blood or hair follicles for testing.  DNA from blood 
samples was extracted using Puregene whole blood extraction kit (Gentra Systems Inc., 
Minneapolis, MN) according to its published protocol. Hair samples were processed 
using 20-30 hair bulbs according to a personally optimized Gentra protocol with a Gentra 
DNA purification kit. The hair bulbs were placed in 200 µl Gentra Cell Lysis solution 
and 0.01 mg proteinase K (Sigma-Aldrich, St Louis, MO) and incubated at 55°C over 
night then DNA was purified by following remaining steps from published Gentra 
protocol.   
Illumina Equine SNP50 Genotyping 
Initial SNP genotyping of 40 samples in the case/control group was performed 
utilizing the Illumina Equine 50 SNP chip for a WGA study. DNA was provided to the 
core facility at the Mayo Clinic in Rochester, MN for genotyping.  
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Sequenom 
Ten SNPs from the WGA study and 39 additional SNPs from the EquCab2.0 SNP 
database (http://www.broadinstitute.org/ftp/distribution/horse_snp_release/v2/) were 
selected for testing using the MassArray iPLEX Gold assay on the Sequenom platform.  
Genotyping was performed at Proactive Genomics, LLC; Clemmons, North Carolina.   
The 49 SNPS selected were identified as being between positions of the SNPs flanking 
the region of interest at base pair 41530793 and 44585118 respectively on ECA 20.  
Following testing, 43 of the 49 SNPs provided quality genotyping data.  Of these, 35 
SNPS, with minor allele frequency > 0.01, were used for final association and haplotype 
analysis.  Furthermore, 96% of the submitted samples had fewer than 0.05 genotypes 
missing and were included in analysis.  
 
Genotyping Analysis 
Genotyping data analysis was performed using PLINK v1.06 (Purcell et. al. 
2007).  Association analysis by case/control chi-square was performed on the Illumina 
data.  To minimize error, because of the multiplicity of SNPs tested, an MPERM analysis 
with 10,000 permutations was done and a statistic, EMP 2 (referred to here as corrected 
P) verified possible associations.  Once association was identified, different sized 
haplotypes were tested by chi-square analysis to identify the size and location of the 
highest associated haplotype in the region. Selected haplotypes were phased for all horses 
in this study to clarify familial patterns of transmission. Chi-square association analysis 
was also performed on the Sequenom data to verify association of the SNPs included 
from llumina assay and to identify any new associations. The 35 SNP haplotypes were 
then phased to verify familial patterns and to identify possible recombination locations. 
Haplotype analysis was also performed in Haploview (Barrett et al., 2005) for validation 
of PLINK analysis. Haplotypes were identified using the HAP and PHASE options of 
PLINK. Haplotype frequencies were determined by direct counting. 
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Sequencing 
To investigate candidate genes, exon sequences of two affected horses were 
compared to those of two unaffected horses. The two affected horses were selected as 
unrelated horses with MBC >7.0 and homozygous for the lordosis-associated ECA20 
haplotype. Unaffected horses were selected as unrelated horses with MBC <7.0 and not 
possessing the ECA20 haplotype associated with extreme lordosis. When SNPS were 
identified and confirmed on these four horses, additional control and case horses were 
tested to determine whether there was an association with the lordotic trait. PCR template 
for sequencing was amplified in 20 µl PCRs using 1· PCR buffer with 2.0 mM MgCl2, 
200 lM of each dNTP, 1 µl genomic DNA from hair lysate, 0.2 U FastStart Taq DNA 
polymerase (Perkin Elmer, Waltham, Mass.) and 50 nM of each primer. Template 
product was quantified on a 1% agarose gel, then amplified with BigDye Terminator v1.1 
cycle sequencing kit according to manufacturer’s instructions (Applied Biosystems), 
cleaned using Centri-Sep columns (Princeton Separations Inc.), and run on an ABI 310 
genetic analyzer (Applied Biosystems). Primers were designed in Primer 3 (Steve and 
Skaletsky 1998) using 8 intronic sequences and seven exonic sequences of TRERF1 
(transcriptional regulating factor for CYP11A1), 15 exonic sequences for RUNX2 
(transcription factor associate with osteoblast differentiation) and six exonic sequences 
for CNPY3 (regulates cell surface expression of Toll Receptor 4) (See Table S1). 
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Results 
 
Distribution of MBC 
The distribution of MBC values among the 749 horses in this study was similar to 
that found by Gallagher et al. (2003).  MBC for the 749 ASB horses ranged from 0 cm to 
17 cm; shown in figure 3.3.  Most MBC values appear to fall within a normal population 
distribution with a mean of 3.6 ± 1.9 cm, median of 4 cm and mode of 4 cm.  An MBC of 
7 cm or greater was selected to classify horses as affected based on this value being 
approximately two standard deviations from the mean.  
 
 
 
Figure 3.3: Population Distribution of MBC Among ASB Samples 
X-axis = MBC measure in centimeters.  Y-axis = number of horses. 
 
Whole Genome Scan with Illumina Equine SNP50 Beadchip 
The Illumina Equine SNP50 chip (Illumina) was effective in typing DNA from 
the initial 40 horses.  The 40 individuals had an average call rate of 0.96.  After filtering 
for minimum minor allele frequency 0.01 and genotyping of 0.90 per SNP; 48,165 SNPs 
were retained for data analysis.     
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Table 3.1 shows the top 10 statistically significant results from a 2 X 2 chi-square 
analysis comparing the distribution of SNPs in the DNA of affected and non-affected 
horses.  The most significant association was found on ECA20 for SNP BIEC2_532523 
(P= 6.69E-06) (Figure3.4).  Of the ten most significant P values, 5 occurred for SNPs on 
ECA20 in the 531 kb region between positions 42,062,440 and 41,530,973.  The 
multiplicity of comparisons will result in the spurious discovery of high chi-square 
values; therefore, to control for the multiplicity of comparisons, PLINK was used to 
conduct a Monte Carlo simulation with 10,000 permutations to calculate a corrected P 
value (EMP2) (Figure 3.5).  Only the association with SNP BIEC2-532523 on ECA20 
remained significant (EMP2 p-value 0.017).   
 
Table 3.1: Results from Illumina Equine SNP50 assay. 
CHR BP  SNP-ID  CHISQ P   EMP2 
 
20 41530793 BIEC2-532523 20.28  6.69E-06        0.01699 
X 51065036 BIEC2-1124071 15.66  7.60E-05 0.2554 
20 42062440 BIEC2-532578 15.53  8.12E-05 0.2904 
7 7444796 BIEC2-978005 13.73  0.000211 0.6762 
X 51061227 BIEC2-1124068 13.47  0.000243 0.7091 
7 18839866 BIEC2-984003 13.33  0.000261 0.7326 
28 35119684 BIEC2-739844 13.33  0.000261 0.7326 
20 41576546 BIEC2-532530 13.07  0.000301 0.7931 
20 41604741 BIEC2-532534 13.07  0.000301 0.7931 
20 41625809 BIEC2-532535 13.07  0.000301 0.7931 
 
Case/Control Analysis: 20 lordotic and 20 normal back Saddlebred horses.  Chromosome 
location (CHR), base position on chromosome (BP), SNP identifier (SNP-ID), 2X2 chi-
square value (CHISQ), P value (P), and P value from Monte Carlo correction for number 
of comparison (EMP2) are shown. 
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Figure 3.4: The –log P-values from Association Analyses Plotted by Haploview. 
Chromosomes are differentiated by color. Illumina genotype results from 20 cases vs 20 
controls displayed in haploview. Possible statistical significance indicated on equine 
chromosome 20 with –log10 value greater than 5 which is equivalent to P < . 
 
 
 
 
Figure 3.5: Max-T Permutation Results 
X-axis = chromosomes, Y-axis = transformed EMP2 value.  Ilumina 20 case vs 20 
control data. Possible statistical significance is shown on equine chromosome 20. 
 
Among the affected horses with MBC 7cm or greater, 17 out of 20 were 
homozygous for the T allele of the [BIEC2-532523 T/C] SNP at base pair location 
41530793 on ECa 20.  Among the 20 controls, only 7 were homozygous for this allele. 
This SNP fell in a larger region of homozygosity spanning approximately 3 Mb from 
base position 41,604,741 to 44,512,270, which was identified with the homozygosity 
function in PLINK scanning sliding windows of 30 SNPS,  moving one SNP at a time 
and allowing one heterozygote per window for each segment to be considered 
homozygous. A homozygosity plot for chromosome 20 is shown in figure 3.6.   
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Figure 3.6: Homozygosity Plot Using the SNP Genotypes of 20 Cases vs 20 Controls on  
Equine Chromosome 20. 
The Y-axis is the number of horses.  The X-axis is base pair location on equine 
chromosome 20.  The dark blue line is number of affected homozygous for that genetic 
region.  The pink line represents the number of unaffected homozygous for that region.  
This homozygous region spans approximately 3 Mb from base position 41,604,741 to 
44,512,270. 
 
 
Illumina Haploview Analysis 
 Haploview SNP analysis verified the results gained in PLINK.  The most 
significant SNPS were still BIEC2-532523 (p-value = 6.6E-6) and BIEC2-532578 (p-
value = 8.1E-5).  Figure 3.7 shows the linear relationship of the SNPS on ECA20 for the 
region of association.  The chi-square values for each SNP are plotted by the red line 
above the chromosome.  Darker blocks below the chromosome are indicators of high 
linkage disequilibrium between the two SNPs connected by that particular block.  
 Haploview analysis using the four-gamete rule was applied: for each 
marker pair, the population frequencies of the four possible two-marker haplotypes are 
computed.  Recombination is considered to have taken place if all haplotypes were 
observed with the minimum frequency of 0.01. Figure 3.8 exhibits the results for the 
region of ECA20 showing significant association patterns using four gamete analyses in 
Haploview.  This region spans from BIEC2-532511 to 532579.  The statistical output 
from the analysis is given back in table 3.2.  Blocks 176 and 179 represent the haplotypes 
bearing the most statistically significant association with extreme lordosis.  
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Figure 3.7: Haploview diagram. The Two highest CHISQ peaks in red designate the two 
most highly associated SNPs; BIEC2-532523 and BIEC2-532578. 
 
 
 
Figure 3.8: ECA20 Region of Association from Haploview Four Gamete Analyses. 
The SNP IDs are across the top of the diagram. The dark red blocks indicate LD between 
alleles. Blue blocks indicate likely recombination hot spots.  
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Table 3.2: Haploview Results - Four Gamete Analysis. 
 
Data reflects what is shown in figure 3.9 for the region of ECA20 associated with 
lordosis verifying statistical significance seen with other analysis programs. 
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Sequenom 
To verify the statistical associations found with the Illumina assay, SNPs from the 
candidate region on ECA20 were tested, including 10 SNPS from the Illumina Equine 
SNP50 chip and 25 additional SNPs from the EquCab2.0 SNP database. Association chi-
squared analyses were performed separately for the additional 13 affected and 181 
unaffected horses not previously tested in the WGA study. The association analysis for 
just these new samples is shown in table 3.3 (CHISQ1 and P1).  Based on these 13 
affected horses, the association with BIEC2-532523 remained statistically significant 
with a P-value of 0.036.  (Since this was a comparison with new samples, dictated by the 
original Illumina assay, no statistical correction is necessary to correct for multiplicity of 
testing as done for the previous experiment.) Of the 35 SNPs, 7 showed statistically 
significant associations (P< 0.05).   When all 33 affected horses and 287 controls were 
compared, 21 of the 35 selected SNPs showed statistical significance in their distributions 
between the two groups based on their relative frequencies.   
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Table 3.3: Results from Sequenom assay Using 35 SNPs from the Candidate Region.   
SNP-ID  BP  CHISQ P           CHISQ2         P2 
BIEC2_532523* 41530793     4.416 0.0356  23.72        1.12E-06 
BIEC2_532534* 41604741     11.19 0.00082 43.72        3.79E-11 
BIEC2_559789 41772507      0.7726 0.3794  5.543        0.01855 
BIEC2_559792 41823842      0.2935 0.588  9.102        0.002553 
BIEC2_532578* 42062440      5.605 0.01791 42.03        8.99E-11 
BIEC2_559853 42305090      0.8888 0.3458  1.363        0.2431 
BIEC2_559859 42395887      1.484 0.2231  1.669        0.1964 
BIEC2_559873 42482150      2.066 0.1506  7.259        0.007055 
BIEC2_532658* 42603867      8.571 0.003415 29.79        4.80E-08 
BIEC2_559931 42679616      0.5499 0.4584  4.836        0.02787 
BIEC2_559976 42757527      0.4859 0.4858  2.909        0.08809 
BIEC2_560005 42806550      1.517 0.2181  3.629        0.05679 
BIEC2_560049 42906719      3.046 0.08091 0.002347    0.9614 
BIEC2_532826 42983718      1.666 0.1969  13.07        0.0003 
BIEC2_560102 43022942      0.8888 0.3458  1.828        0.1763 
BIEC2_560144 43069858      0.8056 0.3694  1.711        0.1908 
BIEC2_560178 43195488      2.306 0.1288  10.9        0.000963 
BIEC2_560197 43241900      1.747 0.1862  3.929        0.04746 
BIEC2_560209 43319368      9.93 0.001626 20.93        4.76E-06 
BIEC2_560255 43433802      1.213 0.2707  9.956        0.001603 
BIEC2_533020 43520722      6.459 0.01104 24.51        7.38E-07 
BIEC2_560328 43548897      1.173 0.2788  10.58        0.001144 
BIEC2_560360 43605858      1.11 0.2921  9.664        0.001879 
BIEC2_560386 43690935      2.254 0.1333  13.48        0.000241 
BIEC2_560457 43914236      1.056 0.304  2.418        0.1199 
BIEC2_560475 43971596      0.9724 0.3241  2.181        0.1397 
BIEC2_560489 44034799      2.722 0.09899 11.67        0.000634 
BIEC2_533265 44090171      7.979 0.004733 26.6        2.50E-07 
BIEC2_560585 44148267      1.407 0.2356  0.964        0.3262 
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Table 3.3: cont… 
SNP-ID  BP  CHISQ P  CHISQ2 P2 
BIEC2_560618 44188313 0.09612 0.7565  1.771  0.1832 
BIEC2_533376 44241203 3.691  0.05472 19.71          9.03E-06 
BIEC2_560705 44337671 1.659  0.1977  1.456  0.2275 
BIEC2_560742 44403289 1.312  0.2521  0.8528  0.3558 
BIEC2_560796 44484324 1.056  0.3042  8.726  0.0031 
BIEC2_533588 44585118 0.5591  0.4546  1.017  0.3132 
SNP identifier (SNP-ID),  base position on the chromosome (BP) 2X2 chi-square value  
comparing the 13 new lordotic horses to 194 controls (CHISQ1),  associated P value 
(P1), chi-square value for 33 lordotic horses and 296 controls (CHISQ2) and associated P 
values (P2)  are shown.  SNPs that showed statistically significant association with P1 or 
P2 are in bold type.  SNPs used for the definition of haplotypes for this region are 
denoted with “*”. 
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Haplotype Analysis 
Haplotypes from this region (from bp location 41,530,793 to 44,585,118) were 
compared among affected and unaffected horses.  A minimum haplotype that included 
the maximum number of affected horses and the lowest number of non-affected horses 
was identified using the four SNPs BIEC2-532523, 532534, 532578 and 532658 and 
spanned 1,073,074 bp.  Intervening SNPs did not affect haplotype assignment.   These 
four SNPs allowed identification of 13 haplotypes.  The haplotypes and their frequencies 
among affected and unaffected horses are shown in table 3.4.  Haplotypes were identified 
using the –hap-phase option of PLINK.  Haplotype frequencies were determined by 
direct counting.  Only 4 of the haplotypes had frequencies above 0.05 and had a 
cumulative frequency of 0.95 among unaffected horses and 0.93 among affected horses.  
The most common haplotype, TGTG, was the one associated with lordosis.  Haploytpe 
TGTG had a frequency of 0.80 among affected Saddlebred horses and a frequency 0f 
0.39 among non-affected horses.  The population distribution for the TGTG haplogype 
segregated by MBC value can be seen in figure 3.10. Zygosity for this haplotype is 
shown for affected and non-affected horses in table 3.5.  Among the affected horses, 23 
(70%) were homozygous for haplotype TGTG while on 15% of the non-affected horses 
were homozygous.  Among the 33 lordotic horses, seven (21%) were heterozygous for 
haplotype TGTG and three (9%) did not possess haplotype TGTG.  Among non-affected, 
48% were heterozygous and 35% did not possess haplotype TGTG.  Statistical 
comparison of the combined data set to the subset of horses with lordosis was highly 
significant (P <0.00001). 
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Table 3.4: Haplotypes defined by BIEC-532523, 532534, 532578 and 532658 with 
frequencies 
Haplotype Affected (N=33) Non-Affected(N=287)  
TGTG   0.80   0.388 
CACT   0.03   0.232 
CACG   0.06   0.167 
TACT   0.04   0.164 
TGCG   0.05   0.019 
TGTT   0.00   0.012 
CATG   0.02   0.003 
TGCT   0.00   0.003 
CGCT   0.00   0.003 
CATT   0.00   0.002 
TACG   0.00   0.002 
TATG   0.00   0.002 
CGTG   0.00   0.002 
Haplotype frequencies listed among lordotic and non-affected American Saddlebred 
horses. 
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Table 3.5: Haplotype by Affected and Unaffected Status 
Classification 
Number of  
Horses 
TGTG 
Homozygotes 
TGTG 
Heterozygotes 
 
No 
TGTG 
Lordotic 33 23 (70%) 7 (21%) 
 
3 (9%) 
Non-affected 287 44 (15%) 135 (47%) 
 
108 (38%) 
 
Combined 320 67 (21%) 142 (44%) 
 
111 (35%) 
Distribution of haplotypes between affected and unaffected individuals 
 
 
 
 
 
Figure 3.9: TGTG Haplotype Population Distribution Sorted by MBC. 
Results are from all animals genotyped.  The Y–axis represents the percentage of horses 
with each pair of haplotypes.  The X – axis represents the MBC values. 
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Haplotype and MBC Related to Age 
Extreme hereditary lordosis was the subject of this study, with a focus on early-
onset lordosis which is manifested before the horse reaches maturity.  To visualize the 
age of affected horses in the study group as related to haplotype and MBC, figure 3.10 
exhibits the individuals grouped by haplotype plotted in a graph with MBC values on the 
y-axis and age on the x-axis.  Interestingly, all of the affected horses under 10 years of 
age with MBC greater than 7.5cm were homozygous for the associated haplotype.   
 
TGTG Haplotype compared MBC vs AGE
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Figure 3.10: Population Distribution MBC vs. AGE. 
 X-axis = age in years.  Y-axis = MBC in centimeters. Interestingly, most of the more 
extreme MBC values were found in horses less than 10 years of age.  
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Sequenom Haploview Analysis 
Solid Spine Analysis: Haploview analysis of Sequenom data verified 
associations calculated by PLINK.  This method of analysis, searches for a “spine” of 
strong LD from one marker to the next along each leg of the triangles in the LD chart. 
Figure 3.11 gives the graphic image of results using the solid spine analysis option.  
Table 3.6 shows the actual haplotypes, ratios and p-values for each block.  Blocks one 
and two containing a total of 5 SNPs were most significant with p-values < 9E-11. 
 
 
 
Figure 3.11: Haploview Solid Spine Analysis.  
SNP region with LD shown by solid red blocks and recombination spots by blue.  
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Table 3.6: Solid Spine Analysis Results from Figure 3.11. 
 
Haplotype blocks with frequencies, ratios and p-values. 
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Four gamete analysis: Alternate 4-gamete analysis of Sequenom data set gave 
results similar to solid spine analyses.  Figure 3.12 shows the haplotype image. Table 3.7 
gives frequencies, ratios and p-values.  Blocks one and three were most significant.  
Block one containing 2 SNPS had a p-value of 2.05E-11; whereas block 3 with 6 SNPs 
had a p-value of 3.38E-11.   
 
 
 
Figure 3.12: Four Gamete Haploview Analysis. 
Red blocks indicate LD. 
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Table 3.7: Statistics from Four Gamete Analysis in Haploview. 
 
 
 
Candidate Genes 
The SNPs defined an overall region of homozygosity for lordotic horses from 
41.5 Mb to 44.5Mb on ECA20.  The annotated horse genome at ENSEMBL genome 
browser (Hubbard et al., 2009) showed that this region contains 53 known and predicted 
genes.  Three genes were selected as possible candidates based on predicted or known 
function in other species; sequence comparisons for TRERF1 (15 exons), RUNX2 (seven 
exons, eight introns) and CNPY3 (six exons) between normal and affected horses did not 
identify SNPs associated with lordosis. Data on SNPs found and their occurrence among 
the case and control horses are shown in Table S2. 
Figure 3.13 shows the region of association on ECA20 as accessed on ENSEMBL 
genome browser with the location of the statistically significant SNPs labeled.  The genes 
highlighted in blue (CNPY3, TRERF1 and RUNX2) were selected for exon screening 
based on location to associated SNPs and possible roles they play in organismal 
development.  Variations found thus far are in linkage disequilibrium with flanking SNP 
from the Sequenom assay. 
Only one gene, RUNX2, in this region had been implicated in skeletal defects 
based on information from OMIM.  From assessment of other likely gene functions, 
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candidate gene TRERF1 was identified based on its function as a transcription factor.   
Another candidate, RUNX2 has been found to be a scaffold for factors involved in 
skeletal gene expression (Stein et al., 2004) and it plays a role in osteoblast and 
chondrocyte differentiation and migration (Fujita et al., (2004).  The gene CNPY3 was 
selected for exon screening because it contains a trinucleotide repeat in exon 2 and 
trinucleotide repeat expansions have been identified as playing a role in disease 
phenotypes in other species.  TRERF1 has 16 exons that were sequenced and compared 
for 2 normal and 2 lordotic horses.  Likewise, RUNX2 has 9 exons and CNPY3 has 6 
exons that were sequenced and compared.  No SNPs were found associated with lordosis 
in any of the 3 genes screened, compiled results in Table 3.8.   Primers used for 
sequencing of these genes are compiled in table 3.9. 
 
BIEC2_560209, 43319368, 4.76E-06
BIEC2_533020, 43520722,  7.38E-07
BIEC2_533265, 44090171, 2.50E-07
             
BIEC2_532523, 41530793,   3.54E-06
BIEC2_532534, 
41604741, 7.47E-11
BIEC2_532578, 42062440,  5.92E-10
BIEC2_532658, 42603867,  1.29E-07
BIEC2_533376, 44241203, 9.03E-06  
 
Figure 3.13: Region of Association on ECA 20 as Shown on ENSEMBL Genome 
Browser.  
Genes highlighted in blue had exons sequenced to screen for additional associated 
variations. Green boxes and arrows identify approximate locations of associated SNPS 
from table 3.1.  
 
 
97 
 
 
Table 3.8: Results From Sequencing Candidate Genes; Allele Frequencies 
Gene Location  Mutation(q) on EquCab2.0 pp:pq:qq pp:pq:qq Conclusion 
RUNX2 Intron 1 g.44042908_44042909delAT 11:02:00 11:04:00  No assoc. 
RUNX2 Intron 5 g.44188955delT 11:6:0 25:5:0   No assoc. 
TRERF1 Exon3 g.41474935_41474936insCAG 30:16:05 5:01:00  No assoc. 
CNPY2 
 
None found   
 
 No  
evidence 
Allele frequencies for variations found in candidate genes RUNX2, TRERF1 and CNPY2 
in lordotic and normal horses to investigate association of this gene with lordosis. “p” 
represents the number of horses found with the reference type. “q” represents the number 
of horses found with the mutation. 
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Table 3.9: Sequencing Primers for Candidate Genes  
Gene ID Forward Primer Reverse Primer BP begin BP end 
RUNX2  e 1  5’-cacttcgctaacttgtggctg -3’     5’-cgggtgatctcgagaaagag-3’  44102849 44103416 
RUNX2  i 1-2 5’-tgttactcaaaggaaagacaccag-3’   5’-cctttccacgttgataaatatgtg-3’  44042741 44043285 
RUNX2  i 1-2 5’-agaggagtccaagtcaattagagc-3’ 5’-ttaccagaacacacggaatgtaac-3’ 44104971 44105504 
RUNX2  e 2 5’-attcttggtttttaagctttgctg-3’ 5’-aaacactcaaattcatctggacac-3’ 44111870 44112245 
RUNX2  i 2-3 5’-tgacacccttagttgtctaacgag-3’ 5’-attagaagtcaccaatgcttctcc-3’ 44114984 44115524 
RUNX2  e 3 5’-tctcatttagaataaggggtcctg-3’ 5’-ggctaccttatctgggatacattc-3’ 44117689 44118023 
RUNX2  i 3-4 5’-ttgaatgaatgaaacgtaagcaag-3’ 5’-gcttctttgtacagagctttcctc-3’ 44142759 44143292 
RUNX2  e 4 5’-agatgatgcttatgaagcagtttg-3’ 5’-gtgcaagtgaaacctatgagtctg-3’ 44169835 44170215 
RUNX2  i 4-5 5’-agatcaagtgtggaaagttcattg-3’ 5’-tcttccctatcaagaagaatggtc-3’ 44178502 44179044 
RUNX2  e 5 5’-tctagaaagctttgtgctatgcag-3’ 5’-atgagagtgggtttccagttaaag-3’ 44188873 44189238 
RUNX2  i 5-6 5’-aagtagacccacagagacacacac-3’ 5’-tttgcctaaaggaggtagtcattc-3’ 44190086 44190643 
RUNX2  i 5-6 5’-tgtgctactccctctttacctgag-3’ 5’-gggctttacatacattaaccatcc-3’ 44201754 44202304 
RUNX2  e 6 5’-gtttgtcatcttgaaagtgtttgc-3’ 5’-aaaatgggacagtaccaatcagac-3’ 44218256 44218605 
RUNX2  i 6-7 5’-aaagcaaagatacgagatccaaag-3’ 5’-gaaattctcctgagggtcataaac-3’ 44218899 44219446 
RUNX2  e 7 5’-tgggaagctaaagttttcttcttt-3’ 5’-atatattgatacacttgggacgtg-3’ 44220029 44220663 
CNPY3  e 1 5’-gttgccataggtcgctgaggacaccatcc-3’ 5’-gctaactcctaaccaccctctgggcttc-3’ 42019587 42020424 
CNPY3  e 2 5’-gaaatgacgtgagtaggatgagg-3’ 5’-tgaagctctaaggaacaaagcag-3’ 42023229 42023634 
CNPY3  e 3 5’-aaaaattccttcccatagagctg-3’ 5’-atcttccaatgacacccatatca-3’ 42024053 42024453 
CNPY3  e 4 5’-aaggtgaggtcaagtgtgaagag-3’ 5’-tgattctcctgaggaaactgaag-3’ 42025686 42026087 
CNPY3  e 5 5’-cagtttcctcaggagaatcacag-3’ 5’-ttgtcgcaggttattctgtacctg-3’ 42026068 42026498 
 
 
100 
ID column, e = exon and i = intron. 
Table 3.9: cont. 
Gene ID Forward Primer Reverse Primer BP begin BP end 
CNPY3  e 6 5’-ttaagggtctctcacttcctcac-3’ 5’-aggagagaaacgctcagcag-3’ 42026614 42027070 
TRERF1  e 1 5’-acgtgatctgttctcatgttgaag-3’ 5’-ttctccagaggtgtctaattctctc-3’ 41554583 41554104 
TRERF1  e 2 5’-cagtgacatgagagtgggtgag-3’ 5’-gtgcactttctaagtctacctatgc-3’ 41501808 41501430 
TRERF1  e 3a 5’-aaatactttcctgtcctttgcatc-3’ 5’-cacgtagctggacatggtttc-3’ 41476107 41475520 
TRERF1  e 3b 5’-ttccctcaagatactcgagacg-3’ 5’-catttcttgcatcgacatacg-3’ 41475646 41474951 
TRERF1  e 3c 5’-cagtattacccacagcagcaac-3’ 5’-ccctgtagcacactaagacacc-3’ 41475013 41474324 
TRERF1  e 4 5’-gaagtctcaggtgaggaagagc-3’ 5’-taggcacgtggtaatcctgtc-3’ 41473091 41472641 
TRERF1  e5  5’-tctgaagggtattggagtgatg-3’ 5’-aatggaagtgggactgtttgac-3’ 41472108 41471624 
TRERF1  e 6 5’-acctttctggaaaagcaaagtg-3’ 5’-aagagctgtcctcatctccaag-3’ 41470844 41470388 
TRERF1  e 7 5’-aaagcccaggtatctgaatcg-3’ 5’-taagtatttccagcaccagcac-3’ 41467098 41466515 
TRERF1  e 8 5’-agctccttggagactagtggtg-3’ 5’-gtggttaagttggtgtgctctg-3’ 41466120 41465719 
TRERF1  e9&10 5’-tcttaggatcacgctgtgagg-3’ 5’-aaacctgggaaaacagtttcag-3’ 41464789 41464197 
TRERF1  e 11 5’-agaggaggccccactatctc-3’ 5’-aagcagcaattaggacagaagc-3’ 41463180 41462699 
TRERF1  e 12 5’-ttcagggctgctaaccattatac-3’ 5’-ccgatgtcagataccatccttc-3’ 41454845 41454445 
TRERF1  e 13 5’-ggagtgagaactgaatggatcg-3’ 5’-ctctccatagcaggaagtcagg-3’ 41452870 41452410 
TRERF1  e 14 5’-atgcagaaagaaagcagtgcag-3’ 5’-acggagtgaaagaaggaaaacc-3’ 41446860 41446362 
TRERF1  e 15 5’-tgccctgtcgttagactgtttc-3’ 5’-agaccccaaggatggtatgag-3’ 41444066 41443606 
TRERF1  e16a 5’-caaaccagatgtcagaccacac-3’ 5’-aatgtagcccagatgaaacacc-3’ 41440537 41439849 
TRERF1  e16b 5’-gtggtcgttttcttgcagtttag-3’ 5’-accttttcaaatgacgtgtgtg-3’ 41439995 41439529 
 
 
Discussion 
The distribution of MBC measurements in this study confirmed the results from 
the earlier study that described a normal distribution of the MBC phenotype, with 5% 
falling two standard deviations above the mean (Gallagher et al., 2003). In that previous 
study, the mean MBC was 4.05 cm, while the mean found in this study was smaller, 3.6 
cm.  Differences in age of horses may account for this discrepancy, because the previous 
study showed a positive correlation for age and MBC; the mean age in the first study was 
7.8 years, whereas the mean age in this study was 7.1 years. 
The WGA study demonstrated the presence of a recessive gene responsible for the 
lordotic trait in horses.  This was suggested in the initial WGA study with 40 horses and 
the Illumina SNP chip (corrected P = 0.017).  The association was confirmed in a 
subsequent study with a second set of affected horses using SNPs from this targeted area 
(P = 0.036).  This haplotype spanned 1 073 074 bases and harbored 53 known and 
predicted genes. 
The TGTG haplotype was the most common and suggests that the haplotype 
occurred in the breed prior to the mutation causing extreme lordosis. If a gene present in 
this haplotype was indeed mutated to cause lordosis, then only knowing the specific 
mutation would allow us to distinguish between these haplotypes.  Of course, mutations 
which subsequently occurred within the lordosis-causing haplotype might allow us to use 
tests for other markers to identify haplotypes completely associated with extreme 
lordosis. 
The high frequency of this haplotype and this phenotype among ASB horses 
might be the consequence of selection by breeders.  If a single copy of the gene produced 
a desirable phenotypic effect, such as improved gait, selection for that trait may negate 
selection against lordosis and result in a net increase in the frequency of the gene in the 
breed. Comparisons of gene frequencies for the TGTG haplotype among horses with 
different performance phenotypes will be needed to answer this question.  
While the high homozygosity of this haplotype among the lordotic horses strongly 
suggests the presence of a recessive gene for the trait, not all lordotic horses were 
homozygous for the region. We found five different haplotypes among the lordotic 
horses, and 30% were not homozygous for the haplotype associated with the recessive 
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lordotic condition. The lordotic phenotype may have multiple possible causes, of which 
the hereditary recessive condition is only one. While 70% of the lordotic horses were 
homozygous for this haplotype, we observed seven (21%) lordotic horses that were 
heterozygous and three (9%) that did not have the haplotype at all (Table 4). There may 
be multiple causes of extreme lordosis among Saddlebred horses, and the recessive gene 
suggested by this study may be only one of them. Other genes, accidents affecting 
skeletal integrity or even management practices may lead to extreme lordosis in the 
absence of the recessive gene implicated by this study. Nevertheless, considering the high 
prevalence of this haplotype among affected horses, this hereditary recessive condition is 
probably the most common cause of lordosis among Saddlebred horses. 
Increased homozygosity of this region and frequency of the haplotype in the 
population raised a new question: Is this haplotype frequency a result of transmission 
distortion (TD) and not just breeder selectivity?  TD, also known as segregation 
distortion, is a preferentially transmitted haplotype that shows a separation from 
Mendel’s law of independent segregation for alleles. A haplotype exhibiting TD in mice, 
known as the t haplotype, was first recognized in 1927 (Dobrovolskaia-Zavadskaia, 
1927).  In mice this haplotype results from a chromosomal inversion including the mouse 
major histocompability complex (MHC) on mouse chromosome 17 (Shin et al., 1982, 
Silver 1982). The transmission ratio for some of these TD alleles can exceed 95% in mice 
(Braden, 1971).   TD has been investigated in an extended American Standardbred family 
of horses involving the gene A10 in the MHC.  Significant TD was found only within that 
family and it was theorized A10 is not the cause of the TD but is linked to the gene 
responsible in that family (Bailey, 1986). In humans, statistically significant evidence for 
TD was noted in male parents of European ancestry for chromosome 6p in the region 
containing the genes SUPT3H and RUNX2 (Santos et al., 2009). The synteny this region 
shares with the region of interest in Saddlebreds may warrant a new look at the haplotype 
associated with extreme lordosis to rule out transmission distortion as a potential cause 
for its high frequency.   
As noted above, the lordosis region contains 53 known or predicted genes. Three 
of these genes; RUNX2, TRERF1, and CNPY3 were selected for exonic sequencing in the 
hope of identifying a causative variation. From assessment of other likely gene functions, 
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the candidate gene TRERF1 was identified based on its function as a transcription factor. 
CNPY3, a trinucleotide repeat-containing gene, was also considered, because repeat 
expansion has been shown to play a role in various diseases. Spinocerebellar ataxia type 
1 is caused by such a repeat expansion within ataxin 1 gene on human 6p (Kameya et al., 
1994).  However, exon sequencing of the three candidate genes did not identify SNPs or 
other genetic variations associated with the trait. 
Though no associated variations were identified during the course of this project, 
RUNX2 could still be considered a viable candidate. Only exonic sequence based on 
Ensembl was analyzed.  RUNX2 has two isoforms that have different N-termini and are 
controlled by two different promoters (Komori and Kishimoto, 1998).  Further 
sequencing is necessary to ensure both isoforms of the gene were completely covered and 
of the known promoter regions were adequately represented.  RUNX2 is a transcription 
factor with many functions.  It is a scaffold for factors involved in skeletal gene 
expression (Stein et al., 2004) and has a role in osteoblast and chondrocyte differentiation 
and migration (Fujita et al., 2004). It is highly expressed in immature osteoblasts, but 
expression must be down regulated for osteoblasts to mature properly (Maruyama et al., 
2007).  
Another gene from this region which could be a plausible candidate is CUL7, a 
gene implicated in skeletal development and distally closer than RUNX2 to the most 
highly associated SNPs in this study.  Short stature syndrome of the Yakut people is 
attributed to a variation in CUL7, a homozygous T insertion at position 4582 in exon 25. 
Two physiological manifestations of this variant in the Yakut are hyper lordosis of the 
lumbar region and hypoplasia of the 13th rib (Maksimova et al., 2007).  Other CUL7 
variations are responsible for 3M syndrome.  There is genetic heterogeneity in 3M 
syndrome after a large-scale mutation search.  The distinguishing features of 3M are 
growth retardation, long slender tubular bones, and tall vertebral bodies (Huber et al., 
2009). 
Rooney & Robertson (1996) distinguished between senile lordosis and congenital 
lordosis in horses.  Senile lordosis was a consequence of aging. Congenital lordosis 
occurred as a consequence of hypoplasia of the articular facets of thoracic vertebrae and 
followed birth as a result of weight bearing (Rooney & Pickett, 1967).  We believe that 
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the condition we have been investigating in ASB horses is the congenital form because 
most of the affected horses were under the age of 10.  However, this should be confirmed 
by sequential measurement of MBC in horses of different ages, concentrating especially 
on young horses, to determine the progression of lordosis.  This could be accomplished 
with a cohort study, following horses from weaning to 2 years, measuring MBC every 30 
days.  To facilitate future investigations, a better physiological characterization needs to 
be developed; with photos, measurements and radiographs of the spinal facets, noting the 
vertebrae involved. This would help better understand the degree of hypoplasia involved 
with congenital lordosis.   
Discovery of the genetic basis for extreme lordosis is a goal that remains elusive.  
In connection with this project, exons of several candidate genes were sequenced. 
However, the cause of the trait could be the result of changes in gene expression which 
would not be uncovered by exon sequencing.  As we learn more about the genome of 
animals, we realize that even the introns and the DNA between genes can play a role in 
gene regulation.  The region of interest might be reduced by further studies using 
additional genetic markers from this region, including more SNPs, microsatellites or 
other genetic polymorphisms.  Deep resequencing of the genes within the target area is a 
valid next step toward identifying rare variants associated with lordosis. Even when an 
associated variant is located, functional studies may be necessary to elucidate the role the 
variant plays, especially a variant not within a gene coding region or known 
activator/inhibitor/enhancer site. This was the case when two of the SNPs associated with 
increased risk for coronary artery disease (CAD) and myocardial infarction (MI) to 
9p21.3, a barren, gene free region (Samani et al., 2007; Schunkert et al., 2008, 2011). It 
turned out the CAD risk alleles were located in a STAT1 binding site identified during a 
study that identified enhancers in this genomic region (Harismendy et al., 2011). 
Another approach to understanding this condition may be to investigate 
differences in gene expression between affected and unaffected horses. Discovery of a 
gene which shows differential expression would help to focus this work. However, the 
choice of tissues and the age at which horses are tested may be factors which confound 
such an approach. This could be accomplished with as few as two full sibling weanlings, 
one exhibiting the lordotic phenotype and one normal. One would sample tissue from the 
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developing thoracic spinal facets from the two. This tissue could then be used in gene 
expression analysis. Data could be compared among genes known to interact within the 
same developmental pathway for bone development.   
More insight into the variation responsible for early-onset extreme lordosis in 
horses may be beneficial for studies of human juvenile kyphosis and juvenile idiopathic 
scoliosis (IS). As with the horse, these two congenital conditions exhibit an early age of 
onset. Familial IS only accounts for 10% of all cases in humans, while 90% appear to be 
sporadic with unknown or environmental aetiological factors (Cheng et al., 2007). 
Through familial linkage analysis, candidate regions for IS susceptibility have been 
identified on human chromosomes 6p, 10q and 18q (Wise et al., 2000). More recently, 
regions on 6, 9, 16 and 17 were identified through genome-wide screening (Miller et al., 
2005). It is of particular interest to note that the segment on HSA6 implicated in the Wise 
paper is syntenic with the region on ECA20 that was found in this study to be associated 
with extreme lordosis.  
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CHAPTER FOUR: Discussion of the Champagne and Lordosis Genetic 
Studies 
  
Introduction 
Chapters 2 and 3 describe studies designed to better understand the genetics of two 
traits in horses, namely champagne dilution and extreme lordosis.  Champagne dilution 
was well known to be the consequence of a Mendelian dominant gene. The task described 
here was to identify the chromosome region harboring the gene, locate the gene 
responsible and identify the likely mutation.   In contrast, extreme lordosis of American 
Saddlebred horses was thought to have a hereditary basis but this was not well established.  
The results of this study confirmed that the trait did have a strong hereditary component, 
localized a major gene responsible for the trait to chromosome 20, suggested the gene 
acted with a recessive mode of inheritance, but did not lead to identification of the gene 
responsible.   
These studies were conducted in a conventional fashion, using the best genomic 
tools available at the time, and the results were classic.  Linkage was found in family 
studies for champagne dilution and association was found with the GWAS study for 
extreme lordosis.  In both cases the underlying hypothesis being tested was that a single 
major gene was responsible for the trait being studied.   However, had the genetics of these 
traits been different we would have obtained different results.  The question arises, how 
might the results appear under different genetic models and how might they have been 
interpreted?   
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Impact of Proper Phenotyping 
 
Champagne Dilution 
The Champagne dilution gene dilutes both black and red hair pigment.  The effect 
of the Champagne dilution gene on red pigment is similar to the effects of the Cream 
dilution gene on red pigment.  Chestnuts with the Champagne gene are termed Gold 
champagne but appear very similar to chestnuts with the Cream dilution (CR) gene 
(palominos).  Had we not known of the difference and pooled data from the two types of 
horses, the results of our study would not have been very clear.  Linkage mapping is based 
on combined results from testing families.  Linkage identified between phenotype and a 
marker with a calculated LOD score of 3 or greater is considered to be statistically 
significant.  Linkage of a genetic marker with Champagne may be identified in one family 
but not other families.  If the gene segregating with the dilution phenotype had actually 
been Cream and not Champagne in one of the families, then the data for that family would 
be in conflict with the data from other families.  For example:  What if three families, 
segregating for a hair color dilution gene were genotyped and two of the families had the 
CH gene while the third did not?  In this case, the LOD the score for family-1 could be 3.4, 
family-2 could be 2.7 and family-3 could be -2.6.  The score for family-1 is statistically 
significant since it is greater than 3.0.  The score for family-2 is not statistically significant 
by itself but can be combined with that of family-1 to give a total LOD score of 6.1.  , The 
score from family-3 raises questions because it is less than -2.0 and therefore evidence 
against linkage.   If we add -2.6 to the other two scores, we still have evidence for linkage 
to those markers because the score is +3.5.  However examination of the data from each 
family would alert us that the genetic basis for dilution in Family-3 lies elsewhere.  The 
ability to detect genetic heterogeneity is one of the strengths of linkage mapping. 
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It is possible for a horse to possess one or two copies of both CH and CR 
simultaneously, because they reside on different chromosomes.  A horse possessing both 
dilutions is called an Ivory Cream and would appear as pale gold.  Genotyping a family 
with a sire possessing both CH and CR would have proven confounding and inconclusive.  
Some dilute offspring would segregate with the sire’s CR allele and some would segregate 
with the CH.  With the phenotype considered the same, statistical significance would not 
be easily attained.  
Fortuitous selection of a single true Champagne family would have permitted 
discovery of linkage and we could have continued the study and identified the gene and 
mutation as described in Chapter 2.  However, when we began to use the test for the gene 
on the general population we would have found many horses exhibiting a dilution 
phenotype without having the Champagne gene.  Every horse with the Champagne gene 
would exhibit dilution so we would know that the results were correct, except there was 
another genetic basis for dilution.   
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Examples of Similar Phenotypes Caused by Different Genes 
Splashed White 
Horses with the splashed white phenotype have blue eyes, and smooth, clearly 
defined white markings of the legs underbelly and face.  They have the appearance of 
being dipped feet first in white paint.  Three different variants in two different genes have 
been found to be responsible for Splashed White (SW) to date: SW1, SW2 and SW3.  When 
the first variant responsible was identified, it did not account for all individuals exhibiting 
the splashed white phenotype.  Upon further investigation, two other genetic variants were 
found responsible for the remaining cases of splashed white.  SW1 is caused by an 11 SNP 
insertion in microphthalmia-associated transcription factor (MITF) promoter 1; SW2 is 
caused by a SNP resulting in an amino acid change in paired box domain gene family 3 
(PAX3); and SW3 is the result of a 5 base pair deletion in exon 5 of MITF causing a frame 
shift and premature stop codon resulting in a truncated protein.  These three loci do not 
account for all the splashed white phenotypes, leaving more to be discovered (Hauswirth et 
al 2012).  . 
Sabino (White Spotting Pattern) 
Sabino is a white spotting pattern in horses with white patches on the legs belly and 
face and some white hairs mixed in with the base colored hairs in the midsection of the 
body.  The variant responsible for Sabino in Tennessee Walking Horses and other light 
horse breeds was identified as a single intronic base change that resulted in skipping of 
exon 17 in the KIT gene.  This particular variant was designated Sabino1 (Sb1), because it 
did not explain all the Sabino phenotypes, such as the one possessed by Clydesdale horses 
(Brooks et al., 2005).  Presumably a different genetic variant is responsible for sabino 
color patterns in Clydesdale horses.   
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Junctional Epidermolysis Bullosa (JEB) 
JEB is an autosomal recessive trait that affects the integrity of the skin and mucosa 
and causes neonatal blistering and skin fragility.  Candidate genes for the condition were 
LAMA3, LAMB3 and LAMC2 genes which make up the three glycoprotein subunits of 
Laminin5, a basement membrane protein required for normal function of the dermal-
epidermal junction.  A defect in any one of these genes could have resulted in JEB, 
affecting Belgian horses, other draft breeds and American Saddlebred Horses (Frame et al 
1988; Kohn et al. 1989; Lieto et al., 2002; Milenokovic et al., 2003).  The variant 
responsible for JEB in Belgian and other draft horse was a single base insertion that 
introduced a premature stop codon in the LAMC2 gene which is located on chromosome 5 
(Spirito et al., 2002). However, this mutation did not explain JEB for American Saddlebred 
horses.  Subsequent studies revealed that  6589 bp deletion spanning exons 24-27 of the 
LAMA3 gene on chromosome 8 was the cause of JEB in American Saddlebred Horses.  A 
random sample set from all cases of JEB, irrespective of breed might not provide for an 
informative GWAS.  This situation highlights the value of conducting genetic studies 
along breed lines.  
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Impact of Different Mutations at the Same Locus (Genetic Heterogeneity) 
 
Champagne Dilution 
Champagne dilution is the result of one variation within a single gene that accounts 
for all cases of Champagne across all the breeds tested.  Some genetic investigations do not 
end so concisely.  Some lead to the discovery that a single variant within that gene does 
not explain all cases.  Different variations in the same gene may be responsible for a single 
phenotype between different families, ethnicities, geographic populations and/or breeds.  
This has been noted in a 1989 review of human research of Cystic Fibrosis (CF).  About 
70% of the cases of CF are caused by one particular mutation and the remainder of the 
cases caused by almost 230 other variable mutations within the same gene (Kerem et al., 
1989).   Early characterization of the gene responsible for Duchenne’s muscular dystrophy 
found multiple deletion events to be responsible for about half of the cases, with other 
cases caused by other types of genetic variation within the same gene (Koenig et al., 1987).   
 
KIT Heterogeneity 
Heterogeneity within a single gene is seen in horses as well.  The KIT gene has 
been implicated in many white spotting patterns in mammals.  Dominant White (DW) in 
horses has been found to be the result of several different spontaneous variations which 
arise in the KIT gene.  A single mutation was found responsible for dominant white horses 
found in the Franches-Montagnes breed, while another variation was found to cause DW in 
a family of Arabian horses.   For Camarillo White horses yet another mutation in KIT was 
found to be responsible (Haase et al. 2007).  Since then even more variants have been 
found to be responsible for other cases of Dominant White (Haase et al. 2009, Haase et al. 
2010).   These studies were based on testing individual families.  If multiple causative 
variants were found in that one gene locus for different families or breeds of horse during 
the course of sequencing the exons of SLC36A1 for Champagne, then it could have been 
concluded the basis of Champagne was heterogeneous. 
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Aggrecan Heterogeneity 
Similar results came from investigation of the Aggrecan gene when looking for 
the cause of dwarfism in miniature horses.  A GWAS revealed a point of statistical 
significance on chromosome 1 showing a region where Aggrecan (ACAN) resided as 
responsible for dwarfism. Based on sequencing ACAN for dwarf horses it was discovered 
that there were at least 4 different recessive variants within the ACAN gene responsible 
for dwarfism (Eberth, 2013). The mutations destroy or alter the function of the ACAN 
gene and any combination of these 4 mutations (in other words, absence of the normal 
allele) result in a dwarf offspring or fetal/embryonic abortion.  
 
GWAS as a Tool to Find Champagne 
If families had been unavailable we could have used the SNP chip and we may 
have obtained similar results.  As long as the sample dilute horses were correctly 
phenotyped as Champagne, the results would be clear and significant.  Several hundred 
SNPs from equine chromosome 14 are represented on the SNP chip.  Some of those would 
have shown statistically significant linkage to Champagne upon analysis.  We would have 
then proceeded to select candidate genes for sequencing and found the mutation 
responsible.  However, if we had grouped all the Cream and Champagne horses as dilute, 
and looked for association, the study would have been less conclusive.  The number of 
horses tested would have been small and the genetic associations for CR and CH might not 
have been strong enough to achieve statistical significance for either genetic location.  
Considering the strong evidence that the dilution exhibited a clear Mendelian mode of 
inheritance, this would have been difficult to explain.  The explanation would have to be:  
1) The SNPs under study were not sufficiently close to the causative gene for detection.  If 
the gene fell among those which were not mapped and annotated, relegated to chromosome 
UN, then this might occur.  2) There was genetic complexity confounding the simple 
model we were testing.  Testing a larger number of horses might have provided statistical 
significance to genotyping analysis results for CH and CR, but without correct phenotyping 
the results would be difficult to decipher.  Fortunately, for our actual study we could 
distinguish between CR and CH and our results were clear, significant and conclusive.   
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Impact of Unknown Mode of Inheritance 
Extreme Lordosis 
Extreme lordosis is often associated with old horses whose backs sag due to 
weakness, overloading or overuse.  However there is another form of extreme lordosis 
found in many breeds in which the condition appears at birth or within the first two years 
(Rooney & Pickett 1967; Rooney, 1969).  Early onset extreme lordosis, the focus of our 
study, occurs about 1% of the time for most breeds, but in the American Saddlebred an 
occurrence rate of nearly 4% was noted, giving rise to the hypothesis that extreme lordosis 
has a hereditary component in this breed (Gallagher et al., 2003).  At the time we 
undertook the investigation its mode of inheritance was not known.  It could have been 
dominant with incomplete penetrance, recessive or polygenic with a complex inheritance 
pattern involving multiple genes of relatively small contribution across the genome.  
The lordosis project was different from the search for Champagne: the mode of 
inheritance was unknown and adequate family samples for a linkage study could not be 
obtained.   Many breeders considered it a defect and avoid matings which produce the trait, 
thus making them less likely to create families for linkage study.  The new equine SNP 
chip had just become available when this project began and sufficient population samples 
were available for a case vs. control genome wide association study (GWAS).  The data 
collected identified statistically significant association with a genetic location on equine 
chromosome 20 and indicated a recessive mode of inheritance (Cook et al., 2010)  If this 
significant association had not been found, we would have looked into it as having 
potentially polygenic inheritance.  Dominance would not have been considered unless 
there had been statistical association with a single SNP genotype with little or no 
homozygosity among the samples.  Complex inheritance is responsible for many 
measureable traits studied in livestock such as milk production in dairy cattle and growth 
rates in beef cattle.  A good review of dairy cattle QTL studies that collated the data across 
several mapping projects identified two consensus regions on bovine chromosome 6 that 
affect milk yield (Raadsma, 2004).  In beef cattle, QTLs have been mapped in association 
for growth rate and other meat traits (Kim et al., 2003Nkrumah et al., 2007; Sherman et al., 
2008; Gutiérrez et al., 2009; Snelling et al., 2010), QTL investigations  of Osteochondrosis 
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dissecans (OCD) in horses have been undertaken with GWAS using mainly 
microsatellites.  To date, fourteen quantitatitive trait loci have been found to play a role in 
OCD, but only a few match locations between the different breeds of horse (Distl, 2013).  
If no single genetic location had been found responsible for lordosis, multiple genetic 
locations with possible additive effects would have been included and potential heritability 
would have been calculated for each gene or region.   
 
Complex Mode of Inheritance: Size Variation in the Horse 
 The many modern breeds of horse encompass a large amount of size variation, 
from the tiniest of miniature horses at less than three feet tall to the largest of draft breeds 
that can top out over 6 feet tall at the withers.  In a search for genetic components involved 
in size variation, a GWAS was completed with 48 horses across 16 breeds.  All horses had 
33 measurements taken of the head, neck, trunk and limbs.  Four loci were identified on 
chromosomes 3, 6, 9 and 11 that together explain 83% of the size variance between these 
48 horses (Makvandi-Nejad, 2012).   
 
Impact of Family Availability 
If families had been available for use with the SNP chip we may have been able to 
identify the trait through linkage studies..  Additional family members could have proven 
helpful in defining borders of the associated homozygous region by exposing possible 
breaks between the associated haplotype and the location where the gene resides.  The 
American Saddlebreds overall, show a strong incidence close interbreeding, where highly 
favored sires are found only 4 and 5 generations back on both the sire and dam side of the 
pedigree for many horses.  The lack of genetic diversity in the region would possibly only 
prove to be confounding in more closely related individuals with the still limited number 
of markers used.    
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Current Scientific Tools and Advances 
Lavender Foal Syndrome 
Lavender foal syndrome is a lethal color dilution in Egyptian Arabian horses with 
an autosomal recessive mode of inheritance.  Lavender’s phenotype had strong parallels 
with two other mutations previously seen in mice one in Ras-associated protein (RAB27A) 
and the other in myosin Va (MYO5A).  The genetic location for Lavender foal was then 
identified using the Equine SNP50 Illumina tool to identify a region of homozygosity 
flanking the MYO5A gene (Brooks et al 2010).  Since no such genetic signature was found 
for RAB27A, this was eliminated as a candidate gene.  
Leopard Complex 
Leopard complex (LP) is characterized as different white spotting patterns in horses 
some involve symmetrical patches of white centered over the hips or complete white body 
and may or may not have pigmented oval spots in the white patterned area (Sponenberg, 
1990).  LP was first mapped to ECA1 with microsatellites in close proximity to Transient 
Receptor Potential Cation Channel Subfamily M, Member 1 (TRPM1) (Terry 2004).  
Significant down regulation of TRPM1 was detected in the skin and retina of LP 
homozygotes using qRT-PCR analysis (Bellone et al., 2008).  Subsequent fine mapping 
and mutation analysis identified one non-coding SNP that was highly associated with LP, 
but it did not show complete LD with LP (Bellone et al., 2010).  Recently a 1378 bp 
retroviral insertion was found in intron1 of TRPM1 that causes a premature poly-
adenylation sight.  This insertion was identified through novel RNA reads from intron 1 of 
TRPM1 found in LP/LP horse skin and retina that had no expression of normal TRPM1 
(Bellone et al., 2013). 
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Lordosis 
Following the discovery of association of early onset extreme lordosis with a 
region on ECA1, several candidate genes (CNPY3, TRERF1 and RUNX2) were identified 
and sequenced.  Sequencing was limited to exons with some partial sequencing of introns 
and the 5’ and 3’ untranslated regions.  In these cases the hypotheses was that the variant 
responsible would be a SNP within an exon which changes the translated product of that 
gene in some way.  But the variant responsible for lordosis could be any one of the genetic 
variations discussed in chapter 1 of this work which qualitatively influence expression.  
The variant may not even be found within the affected gene, but may fall within a 
regulatory site such as a promoter binding site, inhibitor binding site or splice recognition 
site.  Since many genes have interactions with other genes down and around many 
different pathways and processes, several genes and their products could be affected.  
Lordosis may be caused by inadequate development of vertebral facets and.  The lordosis 
gene may influence traits which are being selected for by breeders, such as a higher head 
carriage, more elevated gate or other specific aspect not yet noted which increase the 
incidence of lordosis in this breed.  Perhaps the genes involved are important for skeletal 
or cartilage growth and maturation, since the phenotype develops during the young horses 
growth and maturation.  Growth and maturation are under strict control during 
development giving rise to the idea that it could be caused by a variant involving a 
regulatory element.  The large size of the homozygous region and density of genes 
increases the difficulty in locating the variation responsible.  Some of the horses exhibiting 
extreme lordosis only possessed one copy of the haplotype of interest or did not possess 
the haplotype at all.  The gene responsible may flank the homozygous region and separated 
from the haplotype during a rare recombination event.   
Whole genome sequencing could provide additional info concerning the 
developmental pathway and genes involved.  Since the first complete equine sequence was 
assembled seven years ago, newer sequencing technologies have been developed.  Whole 
genome sequencing is now more affordable and could be used to find the gene responsible 
for lordosis.    One approach to discovering the mutation responsible for the trait would be 
the following.  A small sample selection of four individuals could be sequenced and 
compared: one affected homozygote for the implicated haplotype, one unaffected 
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homozygote, one affected without the haplotype and one unaffected without the haplotype.  
Closely related individuals could be most informative, but unrelated horses would suffice.  
The resulting data might lead to identification of the variant responsible for extreme 
lordosis and could highlight variant’s responsible for others pleotropic traits that are 
selected for by breeders. 
 
Copyright © Deborah G.Cook 2014 
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